ID   SPIKE_SARS2             Reviewed;        1273 AA.
AC   P0DTC2;
DT   22-APR-2020, integrated into UniProtKB/Swiss-Prot.
DT   22-APR-2020, sequence version 1.
DT   02-JUN-2021, entry version 8.
DE   RecName: Full=Spike glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099};
DE            Short=S glycoprotein {ECO:0000255|HAMAP-Rule:MF_04099};
DE   AltName: Full=E2 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   AltName: Full=Peplomer protein {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S1 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S2 {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Contains:
DE     RecName: Full=Spike protein S2' {ECO:0000255|HAMAP-Rule:MF_04099};
DE   Flags: Precursor;
GN   Name=S {ECO:0000255|HAMAP-Rule:MF_04099}; ORFNames=2;
OS   Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2).
OC   Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes;
OC   Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae;
OC   Betacoronavirus; Sarbecovirus.
OX   NCBI_TaxID=2697049;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC RNA].
RX   PubMed=32015508; DOI=10.1038/s41586-020-2008-3;
RA   Wu F., Zhao S., Yu B., Chen Y.-M., Wang W., Song Z.-G., Hu Y., Tao Z.-W.,
RA   Tian J.-H., Pei Y.-Y., Yuan M.-L., Zhang Y.-L., Dai F.-H., Liu Y.,
RA   Wang Q.-M., Zheng J.-J., Xu L., Holmes E.C., Zhang Y.-Z.;
RT   "A new coronavirus associated with human respiratory disease in China.";
RL   Nature 579:265-269(2020).
RN   [2]
RP   FUNCTION (SPIKE PROTEIN S1), AND CLEAVAGE BETWEEN S1 AND S2 BY HOST
RP   TMPRSS2.
RX   PubMed=32142651; DOI=10.1016/j.cell.2020.02.052;
RA   Hoffmann M., Kleine-Weber H., Schroeder S., Krueger N., Herrler T.,
RA   Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A.,
RA   Mueller M.A., Drosten C., Poehlmann S.;
RT   "SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a
RT   clinically proven protease inhibitor.";
RL   Cell 181:1-10(2020).
RN   [3]
RP   CLEAVAGE BETWEEN S1 AND S2 BY HOST FURIN, FUNCTION, AND MUTAGENESIS OF
RP   681-PRO--ALA-684.
RX   PubMed=32362314; DOI=10.1016/j.molcel.2020.04.022;
RA   Hoffmann M., Kleine-Weber H., Poehlmann S.;
RT   "A multibasic cleavage site in the Spike protein of SARS-CoV-2 is essential
RT   for infection of human lung cells.";
RL   Mol. Cell 78:779-784(2020).
RN   [4]
RP   GLYCOSYLATION AT ASN-17; ASN-61; ASN-74; ASN-122; ASN-149; ASN-165;
RP   ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098; ASN-1134; ASN-1158; ASN-1173 AND
RP   ASN-1194, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=32366695; DOI=10.1126/science.abb9983;
RA   Watanabe Y., Allen J.D., Wrapp D., McLellan J.S., Crispin M.;
RT   "Site-specific glycan analysis of the SARS-CoV-2 spike.";
RL   Science 369:330-333(2020).
RN   [5]
RP   GLYCOSYLATION AT ASN-61; ASN-74; ASN-122; ASN-149; ASN-165; ASN-234;
RP   ASN-282; THR-323; SER-325; ASN-331; ASN-343; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098 AND ASN-1194, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RX   PubMed=32363391; DOI=10.1093/glycob/cwaa042;
RA   Shajahan A., Supekar N.T., Gleinich A.S., Azadi P.;
RT   "Deducing the N- and O- glycosylation profile of the spike protein of novel
RT   coronavirus SARS-CoV-2.";
RL   Glycobiology 30:981-988(2020).
RN   [6]
RP   VARIANT GLY-614.
RX   PubMed=32820179; DOI=10.1038/s41598-020-70827-z;
RA   Isabel S., Grana-Miraglia L., Gutierrez J.M., Bundalovic-Torma C.,
RA   Groves H.E., Isabel M.R., Eshaghi A., Patel S.N., Gubbay J.B., Poutanen T.,
RA   Guttman D.S., Poutanen S.M.;
RT   "Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein
RT   mutation now documented worldwide.";
RL   Sci. Rep. 10:14031-14031(2020).
RN   [7]
RP   VARIANT GLY-614, AND MUTAGENESIS OF ASP-614.
RX   PubMed=32697968; DOI=10.1016/j.cell.2020.06.043;
RG   Sheffield COVID-19 Genomics Group;
RA   Korber B., Fischer W.M., Gnanakaran S., Yoon H., Theiler J., Abfalterer W.,
RA   Hengartner N., Giorgi E.E., Bhattacharya T., Foley B., Hastie K.M.,
RA   Parker M.D., Partridge D.G., Evans C.M., Freeman T.M., de Silva T.I.,
RA   McDanal C., Perez L.G., Tang H., Moon-Walker A., Whelan S.P.,
RA   LaBranche C.C., Saphire E.O., Montefiori D.C.;
RT   "Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases
RT   Infectivity of the COVID-19 Virus.";
RL   Cell 182:812-827(2020).
RN   [8]
RP   FUNCTION.
RX   PubMed=32817270; DOI=10.1126/science.abd5223;
RA   Turonova B., Sikora M., Schuermann C., Hagen W.J.H., Welsch S.,
RA   Blanc F.E.C., von Buelow S., Gecht M., Bagola K., Hoerner C.,
RA   van Zandbergen G., Landry J., de Azevedo N.T.D., Mosalaganti S.,
RA   Schwarz A., Covino R., Muehlebach M.D., Hummer G., Krijnse Locker J.,
RA   Beck M.;
RT   "In situ structural analysis of SARS-CoV-2 spike reveals flexibility
RT   mediated by three hinges.";
RL   Science 370:203-208(2020).
RN   [9]
RP   GLYCOSYLATION.
RX   PubMed=32929138; DOI=10.1038/s41598-020-71748-7;
RA   Grant O.C., Montgomery D., Ito K., Woods R.J.;
RT   "Analysis of the SARS-CoV-2 spike protein glycan shield reveals
RT   implications for immune recognition.";
RL   Sci. Rep. 10:14991-14991(2020).
RN   [10]
RP   GLYCOSYLATION AT ASN-17; ASN-61; ASN-74; ASN-122; ASN-149; ASN-165;
RP   ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616; ASN-657; ASN-709;
RP   ASN-717; ASN-801; ASN-1074; ASN-1098; ASN-1134; ASN-1158; ASN-1173 AND
RP   ASN-1194, IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, AND
RP   SUBUNIT.
RX   PubMed=32979942; DOI=10.1016/j.cell.2020.09.018;
RA   Yao H., Song Y., Chen Y., Wu N., Xu J., Sun C., Zhang J., Weng T.,
RA   Zhang Z., Wu Z., Cheng L., Shi D., Lu X., Lei J., Crispin M., Shi Y.,
RA   Li L., Li S.;
RT   "Molecular Architecture of the SARS-CoV-2 Virus.";
RL   Cell 183:730-738(2020).
RN   [11]
RP   VARIANT GLY-614, AND MUTAGENESIS OF ASP-614.
RX   PubMed=33106671; DOI=10.1038/s41586-020-2895-3;
RA   Plante J.A., Liu Y., Liu J., Xia H., Johnson B.A., Lokugamage K.G.,
RA   Zhang X., Muruato A.E., Zou J., Fontes-Garfias C.R., Mirchandani D.,
RA   Scharton D., Bilello J.P., Ku Z., An Z., Kalveram B., Freiberg A.N.,
RA   Menachery V.D., Xie X., Plante K.S., Weaver S.C., Shi P.Y.;
RT   "Spike mutation D614G alters SARS-CoV-2 fitness.";
RL   Nature 592:116-121(2020).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH HUMAN NRP1 AND NRP2.
RC   STRAIN=SARS-CoV-2/human/Liverpool/REMRQ001/2020;
RX   PubMed=33082294; DOI=10.1126/science.abd3072;
RA   Daly J.L., Simonetti B., Klein K., Chen K.E., Williamson M.K.,
RA   Anton-Plagaro C., Shoemark D.K., Simon-Gracia L., Bauer M., Hollandi R.,
RA   Greber U.F., Horvath P., Sessions R.B., Helenius A., Hiscox J.A.,
RA   Teesalu T., Matthews D.A., Davidson A.D., Collins B.M., Cullen P.J.,
RA   Yamauchi Y.;
RT   "Neuropilin-1 is a host factor for SARS-CoV-2 infection.";
RL   Science 370:861-865(2020).
RN   [13]
RP   FUNCTION, AND INTERACTION WITH HUMAN NRP1 AND NRP2.
RC   STRAIN=SARS-CoV-2/human/Finland/1/2020;
RX   PubMed=33082293; DOI=10.1126/science.abd2985;
RA   Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J.,
RA   Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., Smura T.,
RA   Levanov L., Szirovicza L., Tobi A., Kallio-Kokko H., Oesterlund P.,
RA   Joensuu M., Meunier F.A., Butcher S.J., Winkler M.S., Mollenhauer B.,
RA   Helenius A., Gokce O., Teesalu T., Hepojoki J., Vapalahti O.,
RA   Stadelmann C., Balistreri G., Simons M.;
RT   "Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity.";
RL   Science 370:856-860(2020).
RN   [14]
RP   INTERACTION WITH HUMAN ITGA5 AND ITGB1.
RX   PubMed=33102950; DOI=10.1016/j.jacbts.2020.10.003;
RA   Beddingfield B.J., Iwanaga N., Chapagain P.P., Zheng W., Roy C.J., Hu T.Y.,
RA   Kolls J.K., Bix G.J.;
RT   "The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2
RT   Infection.";
RL   JACC Basic Transl. Sci. 6:1-8(2021).
RN   [15]
RP   VARIANT GLY-614.
RX   PubMed=33184236; DOI=10.1126/science.abe8499;
RA   Hou Y.J., Chiba S., Halfmann P., Ehre C., Kuroda M., Dinnon K.H. III,
RA   Leist S.R., Schaefer A., Nakajima N., Takahashi K., Lee R.E.,
RA   Mascenik T.M., Graham R., Edwards C.E., Tse L.V., Okuda K., Markmann A.J.,
RA   Bartelt L., de Silva A., Margolis D.M., Boucher R.C., Randell S.H.,
RA   Suzuki T., Gralinski L.E., Kawaoka Y., Baric R.S.;
RT   "SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and
RT   transmission in vivo.";
RL   Science 370:1464-1468(2020).
RN   [16]
RP   VARIANT GLY-614.
RX   PubMed=33417835; DOI=10.1016/j.celrep.2020.108630;
RA   Gobeil S.M., Janowska K., McDowell S., Mansouri K., Parks R., Manne K.,
RA   Stalls V., Kopp M.F., Henderson R., Edwards R.J., Haynes B.F., Acharya P.;
RT   "D614G Mutation Alters SARS-CoV-2 Spike Conformation and Enhances Protease
RT   Cleavage at the S1/S2 Junction.";
RL   Cell Rep. 34:108630-108630(2021).
RN   [17]
RP   VARIANTS 69-VAL--PHE-70 DEL; LYS-144 DEL; TYR-501; ASP-570; GLY-614;
RP   HIS-681; ILE-716; ALA-982 AND HIS-1118.
RC   STRAIN=20I/501Y.V1, Alpha, B.1.1.7, VOC-202012/01, and VUI-202012/01;
RX   PubMed=33413740; DOI=10.2807/1560-7917.es.2020.26.1.2002106;
RA   Leung K., Shum M.H., Leung G.M., Lam T.T., Wu J.T.;
RT   "Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-
RT   2 in the United Kingdom, October to November 2020.";
RL   Eurosurveillance 26:0-0(2021).
RN   [18]
RP   VARIANT TYR-501.
RX   PubMed=32732280; DOI=10.1126/science.abc4730;
RA   Gu H., Chen Q., Yang G., He L., Fan H., Deng Y.Q., Wang Y., Teng Y.,
RA   Zhao Z., Cui Y., Li Y., Li X.F., Li J., Zhang N.N., Yang X., Chen S.,
RA   Guo Y., Zhao G., Wang X., Luo D.Y., Wang H., Yang X., Li Y., Han G., He Y.,
RA   Zhou X., Geng S., Sheng X., Jiang S., Sun S., Qin C.F., Zhou Y.;
RT   "Adaptation of SARS-CoV-2 in BALB/c mice for testing vaccine efficacy.";
RL   Science 369:1603-1607(2020).
RN   [19]
RP   VARIANT GLY-614, AND MUTAGENESIS OF GLY-614.
RX   PubMed=33636719; DOI=10.1038/s41586-021-03361-1;
RA   Zhou B., Thi Nhu Thao T., Hoffmann D., Taddeo A., Ebert N., Labroussaa F.,
RA   Pohlmann A., King J., Steiner S., Kelly J.N., Portmann J., Halwe N.J.,
RA   Ulrich L., Trueeb B.S., Fan X., Hoffmann B., Wang L., Thomann L., Lin X.,
RA   Stalder H., Pozzi B., de Brot S., Jiang N., Cui D., Hossain J., Wilson M.,
RA   Keller M., Stark T.J., Barnes J.R., Dijkman R., Jores J., Benarafa C.,
RA   Wentworth D.E., Thiel V., Beer M.;
RT   "SARS-CoV-2 spike D614G change enhances replication and transmission.";
RL   Nature 5920:122-127(2021).
RN   [20]
RP   MUTAGENESIS OF ASN-165; ASN-234; ASN-331; ASN-343; LEU-452; ALA-475;
RP   VAL-483; PHE-490 AND HIS-519.
RX   PubMed=32730807; DOI=10.1016/j.cell.2020.07.012;
RA   Li Q., Wu J., Nie J., Zhang L., Hao H., Liu S., Zhao C., Zhang Q., Liu H.,
RA   Nie L., Qin H., Wang M., Lu Q., Li X., Sun Q., Liu J., Zhang L., Li X.,
RA   Huang W., Wang Y.;
RT   "The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and
RT   Antigenicity.";
RL   Cell 182:1284-1294(2020).
RN   [21]
RP   FUNCTION, CLEAVAGE BETWEEN S1 AND S2 BY HOST CTSL, AND INTERACTION WITH
RP   HUMAN ACE2.
RX   PubMed=32221306; DOI=10.1038/s41467-020-15562-9;
RA   Ou X., Liu Y., Lei X., Li P., Mi D., Ren L., Guo L., Guo R., Chen T.,
RA   Hu J., Xiang Z., Mu Z., Chen X., Chen J., Hu K., Jin Q., Wang J., Qian Z.;
RT   "Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and
RT   its immune cross-reactivity with SARS-CoV.";
RL   Nat. Commun. 11:1620-1620(2020).
RN   [22]
RP   INTERACTION WITH HUMAN ACE2.
RX   PubMed=33607086; DOI=10.1016/j.bpj.2021.02.007;
RA   Cao W., Dong C., Kim S., Hou D., Tai W., Du L., Im W., Zhang X.F.;
RT   "Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2
RT   protein-protein interaction.";
RL   Biophys. J. 120:1011-1019(2021).
RN   [23]
RP   FUNCTION, AND CLEAVAGE BETWEEN S1 AND S2 BY HOST TMPRSS2.
RX   PubMed=33465165; DOI=10.1371/journal.ppat.1009212;
RA   Ou T., Mou H., Zhang L., Ojha A., Choe H., Farzan M.;
RT   "Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated
RT   by TMPRSS2.";
RL   PLoS Pathog. 17:e1009212-e1009212(2021).
RN   [24]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH S PROTEIN.
RX   PubMed=33229438; DOI=10.1074/jbc.ra120.016175;
RA   Boson B., Legros V., Zhou B., Siret E., Mathieu C., Cosset F.L.,
RA   Lavillette D., Denolly S.;
RT   "The SARS-CoV-2 Envelope and Membrane proteins modulate maturation and
RT   retention of the Spike protein, allowing assembly of virus-like
RT   particles.";
RL   J. Biol. Chem. 296:100111-100111(2020).
RN   [25]
RP   VARIANTS PHE-18; ALA-80; GLY-215; ASN-417; LYS-484; TYR-501; GLY-614 AND
RP   VAL-701.
RC   STRAIN=20H/501Y.V2, B.1.351, and Beta;
RX   PubMed=33690265; DOI=10.1038/s41586-021-03402-9;
RA   Tegally H., Wilkinson E., Giovanetti M., Iranzadeh A., Fonseca V.,
RA   Giandhari J., Doolabh D., Pillay S., San E.J., Msomi N., Mlisana K.,
RA   von Gottberg A., Walaza S., Allam M., Ismail A., Mohale T., Glass A.J.,
RA   Engelbrecht S., Van Zyl G., Preiser W., Petruccione F., Sigal A.,
RA   Hardie D., Marais G., Hsiao M., Korsman S., Davies M.A., Tyers L.,
RA   Mudau I., York D., Maslo C., Goedhals D., Abrahams S., Laguda-Akingba O.,
RA   Alisoltani-Dehkordi A., Godzik A., Wibmer C.K., Sewell B.T., Lourenco J.,
RA   Alcantara L.C.J., Kosakovsky Pond S.L., Weaver S., Martin D.,
RA   Lessells R.J., Bhiman J.N., Williamson C., de Oliveira T.;
RT   "Emergence of a SARS-CoV-2 variant of concern with mutations in spike
RT   glycoprotein.";
RL   Nature 592:438-443(2021).
RN   [26]
RP   POLYMORPHISM.
RX   PubMed=34142653; DOI=10.2807/1560-7917.es.2021.26.24.2100509;
RA   Campbell F., Archer B., Laurenson-Schafer H., Jinnai Y., Konings F.,
RA   Batra N., Pavlin B., Vandemaele K., Van Kerkhove M.D., Jombart T.,
RA   Morgan O., le Polain de Waroux O.;
RT   "Increased transmissibility and global spread of SARS-CoV-2 variants of
RT   concern as at June 2021.";
RL   Eurosurveillance 26:0-0(2021).
RN   [27]
RP   VARIANTS ARG-452 AND PHE-453, AND MUTAGENESIS OF LEU-452; TYR-453 AND
RP   ASN-501.
RX   PubMed=34171266; DOI=10.1016/j.chom.2021.06.006;
RG   Genotype to Phenotype Japan (G2P-Japan) Consortium;
RA   Motozono C., Toyoda M., Zahradnik J., Saito A., Nasser H., Tan T.S.,
RA   Ngare I., Kimura I., Uriu K., Kosugi Y., Yue Y., Shimizu R., Ito J.,
RA   Torii S., Yonekawa A., Shimono N., Nagasaki Y., Minami R., Toya T.,
RA   Sekiya N., Fukuhara T., Matsuura Y., Schreiber G., Ikeda T., Nakagawa S.,
RA   Ueno T., Sato K.;
RT   "SARS-CoV-2 spike L452R variant evades cellular immunity and increases
RT   infectivity.";
RL   Cell Host Microbe 0:0-0(2021).
RN   [28]
RP   VARIANT 69-VAL--PHE-70 DEL, AND MUTAGENESIS OF 69-HIS-VAL-70.
RX   PubMed=34166617; DOI=10.1016/j.celrep.2021.109292;
RG   COVID-19 Genomics UK (COG-UK) Consortium;
RA   Meng B., Kemp S.A., Papa G., Datir R., Ferreira I.A.T.M., Marelli S.,
RA   Harvey W.T., Lytras S., Mohamed A., Gallo G., Thakur N., Collier D.A.,
RA   Mlcochova P., Duncan L.M., Carabelli A.M., Kenyon J.C., Lever A.M.,
RA   De Marco A., Saliba C., Culap K., Cameroni E., Matheson N.J., Piccoli L.,
RA   Corti D., James L.C., Robertson D.L., Bailey D., Gupta R.K.;
RT   "Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in
RT   the Alpha variant B.1.1.7.";
RL   Cell Rep. 35:109292-109292(2021).
RN   [29] {ECO:0007744|PDB:6M17}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.90 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), DOMAIN, AND INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN S1).
RX   PubMed=32132184; DOI=10.1126/science.abb2762;
RA   Yan R., Zhang Y., Li Y., Xia L., Guo Y., Zhou Q.;
RT   "Structural basis for the recognition of the SARS-CoV-2 by full-length
RT   human ACE2.";
RL   Science 367:1444-1448(2020).
RN   [30] {ECO:0007744|PDB:6VSB}
RP   STRUCTURE BY ELECTRON MICROSCOPY (3.46 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN S1), SUBUNIT, AND
RP   GLYCOSYLATION.
RX   PubMed=32075877; DOI=10.1126/science.abb2507;
RA   Wrapp D., Wang N., Corbett K.S., Goldsmith J.A., Hsieh C.L., Abiona O.,
RA   Graham B.S., McLellan J.S.;
RT   "Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation.";
RL   Science 367:1260-1263(2020).
RN   [31] {ECO:0007744|PDB:6VXX, ECO:0007744|PDB:6VYB}
RP   STRUCTURE BY ELECTRON MICROSCOPY (2.80 ANGSTROMS), FUNCTION (SPIKE PROTEIN
RP   S1), SUBUNIT (SPIKE PROTEIN S1), INTERACTION WITH HUMAN ACE2 (SPIKE PROTEIN
RP   S1), MUTAGENESIS OF 679-GLN--ALA-684, GLYCOSYLATION AT ASN-61; ASN-122;
RP   ASN-61; ASN-165; ASN-234; ASN-282; ASN-331; ASN-343; ASN-603; ASN-616;
RP   ASN-657; ASN-709; ASN-717; ASN-801; ASN-1074; ASN-1098 AND ASN-1134, AND
RP   DISULFIDE BOND.
RX   PubMed=32155444; DOI=10.1016/j.cell.2020.02.058;
RA   Walls A.C., Park Y.J., Tortorici M.A., Wall A., McGuire A.T., Veesler D.;
RT   "Structure, function, and antigenicity of the SARS-CoV-2 spike
RT   glycoprotein.";
RL   Cell 180:1-12(2020).
RN   [32]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HOST ACE2.
RX   PubMed=32225176; DOI=10.1038/s41586-020-2180-5;
RA   Lan J., Ge J., Yu J., Shan S., Zhou H., Fan S., Zhang Q., Shi X., Wang Q.,
RA   Zhang L., Wang X.;
RT   "Structure of the SARS-CoV-2 spike receptor-binding domain bound to the
RT   ACE2 receptor.";
RL   Nature 581:215-220(2020).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.68 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HOST ACE2, INTERACTION WITH HOST ACE2, AND MUTAGENESIS OF GLN-493 AND
RP   ASN-501.
RX   PubMed=32225175; DOI=10.1038/s41586-020-2179-y;
RA   Shang J., Ye G., Shi K., Wan Y., Luo C., Aihara H., Geng Q., Auerbach A.,
RA   Li F.;
RT   "Structural basis of receptor recognition by SARS-CoV-2.";
RL   Nature 581:221-224(2020).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (3.08 ANGSTROMS) OF SPIKE PROTEIN S1 AND IN COMPLEX
RP   WITH HUMAN ANTIBODY CR3022, AND DISULFIDE BOND.
RX   PubMed=32245784; DOI=10.1126/science.abb7269;
RA   Yuan M., Wu N.C., Zhu X., Lee C.D., So R.T.Y., Lv H., Mok C.K.P.,
RA   Wilson I.A.;
RT   "A highly conserved cryptic epitope in the receptor-binding domains of
RT   SARS-CoV-2 and SARS-CoV.";
RL   Science 368:630-633(2020).
CC   -!- FUNCTION: [Spike protein S1]: attaches the virion to the cell membrane
CC       by interacting with host receptor, initiating the infection. Binding to
CC       human ACE2 receptor and internalization of the virus into the endosomes
CC       of the host cell induces conformational changes in the Spike
CC       glycoprotein (PubMed:32142651, PubMed:32221306, PubMed:32075877,
CC       PubMed:32155444). Binding to host NRP1 and NRP2 via C-terminal
CC       polybasic sequence enhances virion entry into host cell
CC       (PubMed:33082294, PubMed:33082293). This interaction may explain virus
CC       tropism of human olfactory epithelium cells, which express high level
CC       of NRP1 and NRP2 but low level of ACE2 (PubMed:33082293). The stalk
CC       domain of S contains three hinges, giving the head unexpected
CC       orientational freedom (PubMed:32817270). Uses human TMPRSS2 for priming
CC       in human lung cells which is an essential step for viral entry
CC       (PubMed:32142651). Can be alternatively processed by host furin
CC       (PubMed:32362314). Proteolysis by cathepsin CTSL may unmask the fusion
CC       peptide of S2 and activate membranes fusion within endosomes.
CC       {ECO:0000255|HAMAP-Rule:MF_04099, ECO:0000269|PubMed:32075877,
CC       ECO:0000269|PubMed:32142651, ECO:0000269|PubMed:32155444,
CC       ECO:0000269|PubMed:32221306, ECO:0000269|PubMed:32362314,
CC       ECO:0000269|PubMed:32817270, ECO:0000269|PubMed:33082293,
CC       ECO:0000269|PubMed:33082294, ECO:0000303|PubMed:33082293}.
CC   -!- FUNCTION: [Spike protein S2]: mediates fusion of the virion and
CC       cellular membranes by acting as a class I viral fusion protein. Under
CC       the current model, the protein has at least three conformational
CC       states: pre-fusion native state, pre-hairpin intermediate state, and
CC       post-fusion hairpin state. During viral and target cell membrane
CC       fusion, the coiled coil regions (heptad repeats) assume a trimer-of-
CC       hairpins structure, positioning the fusion peptide in close proximity
CC       to the C-terminal region of the ectodomain. The formation of this
CC       structure appears to drive apposition and subsequent fusion of viral
CC       and target cell membranes. {ECO:0000255|HAMAP-Rule:MF_04099}.
CC   -!- FUNCTION: [Spike protein S2']: Acts as a viral fusion peptide which is
CC       unmasked following S2 cleavage occurring upon virus endocytosis.
CC       {ECO:0000255|HAMAP-Rule:MF_04099}.
CC   -!- FUNCTION: [Spike glycoprotein]: May down-regulate host tetherin (BST2)
CC       by lysosomal degradation, thereby counteracting its antiviral activity.
CC       {ECO:0000250|UniProtKB:P59594}.
CC   -!- SUBUNIT: [Spike glycoprotein]: Homotrimer; each monomer consists of a
CC       S1 and a S2 subunit (PubMed:32075877, PubMed:32155444,
CC       PubMed:32245784). The resulting peplomers protrude from the virus
CC       surface as spikes (PubMed:32979942). Interacts with ORF3a protein and
CC       ORF7a protein (By similarity) (PubMed:32075877, PubMed:32155444,
CC       PubMed:32245784, PubMed:32979942). There are an average of 26 +/-15
CC       spike trimers at the surface of virion particles (PubMed:32979942).
CC       {ECO:0000255|HAMAP-Rule:MF_04099, ECO:0000269|PubMed:32075877,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32245784,
CC       ECO:0000269|PubMed:32979942}.
CC   -!- SUBUNIT: [Spike protein S1]: Binds to host ACE2 (PubMed:32221306,
CC       PubMed:33607086, PubMed:32075877, PubMed:32132184, PubMed:32155444,
CC       PubMed:32225175, PubMed:32225176). RBD also interacts with the N-linked
CC       glycan on Asn90 of ACE2 (PubMed:33607086). Cleavage of S generates a
CC       polybasic C-terminal sequence on S1 that binds to host Neuropilin-1
CC       (NRP1) and Neuropilin-2 (NRP2) receptors (PubMed:33082294,
CC       PubMed:33082293). Interacts with host integrin alpha-5/beta-1
CC       (ITGA5:ITGB1) and with ACE2 in complex with integrin alpha-5/beta-1
CC       (ITGA5:ITGB1) (PubMed:33102950). May interact via cytoplasmic c-
CC       terminus with M protein (PubMed:33229438).
CC       {ECO:0000269|PubMed:32075877, ECO:0000269|PubMed:32132184,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32221306,
CC       ECO:0000269|PubMed:32225175, ECO:0000269|PubMed:32225176,
CC       ECO:0000269|PubMed:33082293, ECO:0000269|PubMed:33082294,
CC       ECO:0000269|PubMed:33102950, ECO:0000269|PubMed:33229438,
CC       ECO:0000269|PubMed:33607086}.
CC   -!- INTERACTION:
CC       P0DTC2; P0DTC2: S; NbExp=34; IntAct=EBI-25474821, EBI-25474821;
CC       P0DTC2; Q9BYF1: ACE2; Xeno; NbExp=150; IntAct=EBI-25474821, EBI-7730807;
CC       P0DTC2; P30530: AXL; Xeno; NbExp=9; IntAct=EBI-25474821, EBI-2850927;
CC       P0DTC2; P35613: BSG; Xeno; NbExp=7; IntAct=EBI-25474821, EBI-750709;
CC       P0DTC2; Q9NNX6: CD209; Xeno; NbExp=6; IntAct=EBI-25474821, EBI-9257341;
CC       P0DTC2; Q8IUN9: CLEC10A; Xeno; NbExp=4; IntAct=EBI-25474821, EBI-2873246;
CC       P0DTC2; Q8IUN9-2: CLEC10A; Xeno; NbExp=3; IntAct=EBI-25474821, EBI-25776912;
CC       P0DTC2; Q9H2X3: CLEC4M; Xeno; NbExp=5; IntAct=EBI-25474821, EBI-1391211;
CC       P0DTC2; P07711: CTSL; Xeno; NbExp=3; IntAct=EBI-25474821, EBI-1220160;
CC       P0DTC2; P00533: EGFR; Xeno; NbExp=4; IntAct=EBI-25474821, EBI-297353;
CC       P0DTC2; P09958: FURIN; Xeno; NbExp=5; IntAct=EBI-25474821, EBI-1056807;
CC       P0DTC2; Q96D42: HAVCR1; Xeno; NbExp=7; IntAct=EBI-25474821, EBI-953786;
CC       P0DTC2; P01130: LDLR; Xeno; NbExp=4; IntAct=EBI-25474821, EBI-988319;
CC       P0DTC2; P17931: LGALS3; Xeno; NbExp=2; IntAct=EBI-25474821, EBI-1170392;
CC       P0DTC2; P47929: LGALS7B; Xeno; NbExp=2; IntAct=EBI-25474821, EBI-357504;
CC       P0DTC2; O00214: LGALS8; Xeno; NbExp=2; IntAct=EBI-25474821, EBI-740058;
CC       P0DTC2; Q61830: Mrc1; Xeno; NbExp=2; IntAct=EBI-25474821, EBI-642509;
CC       P0DTC2; O14786: NRP1; Xeno; NbExp=9; IntAct=EBI-25474821, EBI-1187100;
CC       P0DTC2; Q96LC7: SIGLEC10; Xeno; NbExp=2; IntAct=EBI-25474821, EBI-8502656;
CC   -!- SUBCELLULAR LOCATION: Virion membrane {ECO:0000255|HAMAP-Rule:MF_04099,
CC       ECO:0000269|PubMed:32979942}; Single-pass type I membrane protein
CC       {ECO:0000255|HAMAP-Rule:MF_04099}. Host endoplasmic reticulum-Golgi
CC       intermediate compartment membrane {ECO:0000255|HAMAP-Rule:MF_04099};
CC       Single-pass type I membrane protein {ECO:0000255|HAMAP-Rule:MF_04099}.
CC       Host cell membrane {ECO:0000255|HAMAP-Rule:MF_04099}; Single-pass type
CC       I membrane protein {ECO:0000255|HAMAP-Rule:MF_04099}. Note=Accumulates
CC       in the endoplasmic reticulum-Golgi intermediate compartment, where it
CC       participates in virus particle assembly. Colocalizes with S in the host
CC       endoplasmic reticulum-Golgi intermediate compartment. Some S oligomers
CC       are transported to the host plasma membrane, where they may mediate
CC       cell-cell fusion (By similarity). An average of 26 +/-15 S trimers are
CC       found randomly distributed at the surface of the virion
CC       (PubMed:32979942). {ECO:0000255|HAMAP-Rule:MF_04099,
CC       ECO:0000269|PubMed:32979942}.
CC   -!- DOMAIN: The KxHxx motif seems to function as an ER retrieval and binds
CC       COPI in vitro. {ECO:0000250|UniProtKB:P59594}.
CC   -!- DOMAIN: Fusion peptide 1 (FP1) and fusion peptide 2 (FP2) function
CC       cooperatively and have a membrane-ordering effect on lipid headgroups
CC       and shallow hydrophobic regions of target bilayers. They are considered
CC       as two domains of an extended, bipartite FP. The membrane-ordering
CC       activity is calcium-dependent and also dependent on correct folding,
CC       which is maintained by an internal disulfide bond in FP2.
CC       {ECO:0000255|HAMAP-Rule:MF_04099}.
CC   -!- PTM: The cytoplasmic Cys-rich domain is palmitoylated. Spike
CC       glycoprotein is digested within host endosomes. {ECO:0000255|HAMAP-
CC       Rule:MF_04099}.
CC   -!- PTM: Specific enzymatic cleavages in vivo yield mature proteins. The
CC       precursor is processed into S1 and S2 by host CTSL, TMPRSS2 or furin to
CC       yield the mature S1 and S2 proteins (PubMed:32155444). CTSL cleavage
CC       would occur in endosomes (PubMed:32221306, PubMed:33465165). TMPRSS2
CC       cleavage would occur at the cell surface, allowing the virus to enter
CC       the cell despite inhibition of the endosomal pathway by
CC       hydroxychloroquine (PubMed:33465165). In addition, a second cleavage
CC       results in the release of a fusion peptide upon viral binding to the
CC       host cell receptor (By similarity). The polybasic furin cleavage site
CC       is absent in SARS-CoV S (PubMed:32155444, PubMed:32362314,
CC       PubMed:33465165). It increases the dependence on TMPRSS2 expression by
CC       SARS-CoV-2 (PubMed:33465165). D614G substitution would enhance furin
CC       cleavage at the S1/S2 junction (PubMed:33417835). {ECO:0000255|HAMAP-
CC       Rule:MF_04099, ECO:0000269|PubMed:32155444,
CC       ECO:0000269|PubMed:32221306, ECO:0000269|PubMed:32362314,
CC       ECO:0000269|PubMed:33417835, ECO:0000269|PubMed:33465165}.
CC   -!- PTM: Highly decorated by heterogeneous N-linked glycans protruding from
CC       the trimer surface (PubMed:32075877, PubMed:32155444, PubMed:32929138).
CC       Highly glycosylated by host both on S1 and S2 subunits, occluding many
CC       regions across the surface of the protein (PubMed:32366695,
CC       PubMed:32363391, PubMed:32929138). Approximately 40% of the protein
CC       surface is shielded from antibody recognition by glycans, with the
CC       notable exception of the ACE2 receptor binding domain
CC       (PubMed:32929138). {ECO:0000269|PubMed:32075877,
CC       ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32363391,
CC       ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32929138}.
CC   -!- POLYMORPHISM: Variant Alpha/B.1.1.7 belongs to a lineage isolated first
CC       in United Kingdom (Dec 2020). It is also called Variant of Concern
CC       (VOC) 202012/01, Variant Under Investigation (VUI) 202012/01, 501Y.V1
CC       or 20B/501Y.V1 (PubMed:33413740). It has an estimated 25% increase of
CC       transmissibility (PubMed:34142653). {ECO:0000305|PubMed:33413740,
CC       ECO:0000305|PubMed:34142653}.
CC   -!- POLYMORPHISM: Variant Beta/B.1.351 belongs to a lineage first isolated
CC       in South Africa (Dec 2020) is also called 501Y.V2. It has an estimated
CC       25% increase of transmissibility. {ECO:0000305|PubMed:34142653}.
CC   -!- POLYMORPHISM: Variant Gamma/P.1 belongs to a lineage first isolated in
CC       Brazil (Nov 2020) is also called 20J (V3) and GR/501Y.V3. It has an
CC       estimated 38% increase of transmissibility.
CC       {ECO:0000305|PubMed:34142653}.
CC   -!- POLYMORPHISM: Variant Delta/B.1.617.2 belongs to a lineage first
CC       isolated in India (Oct 2020) is also called G/478K.V1. It has an
CC       estimated 97% increase of transmissibility.
CC       {ECO:0000305|PubMed:34142653}.
CC   -!- MISCELLANEOUS: Variant D614G has become the most prevalent circulating
CC       sequence in the global pandemic since april 2020 (PubMed:32697968). The
CC       mutation is associated with higher viral loads produced in cell culture
CC       and animal models (PubMed:32697968, PubMed:33106671, PubMed:33184236).
CC       It would not change pathogenicity nor neutralization properties vs
CC       vaccination (PubMed:33184236). May be prevalent because the mutation
CC       increases virus transmission in human population (PubMed:33106671).
CC       {ECO:0000269|PubMed:32697968, ECO:0000269|PubMed:33106671,
CC       ECO:0000269|PubMed:33184236}.
CC   -!- SIMILARITY: Belongs to the betacoronaviruses spike protein family.
CC       {ECO:0000255|HAMAP-Rule:MF_04099}.
CC   -!- CAUTION: Asn-17, Asn-603, Asn-1134, Asn-1158, and Asn-1173 are non
CC       glycosylated when S1 or S2 are expressed individually in HEK293 cells.
CC       {ECO:0000269|PubMed:32363391}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; MN908947; QHD43416.1; -; Genomic_RNA.
DR   RefSeq; YP_009724390.1; NC_045512.2.
DR   PDB; 6LVN; X-ray; 2.47 A; A/B/C/D=1168-1203.
DR   PDB; 6LXT; X-ray; 2.90 A; A/B/C/D/E/F=910-988, A/B/C/D/E/F=1162-1206.
DR   PDB; 6LZG; X-ray; 2.50 A; B=319-527.
DR   PDB; 6M0J; X-ray; 2.45 A; E=319-541.
DR   PDB; 6M17; EM; 2.90 A; E/F=319-541.
DR   PDB; 6M1V; X-ray; 1.50 A; A=917-966.
DR   PDB; 6VSB; EM; 3.46 A; A/B/C=1-1208.
DR   PDB; 6VW1; X-ray; 2.68 A; E/F=455-518.
DR   PDB; 6VXX; EM; 2.80 A; A/B/C=14-1211.
DR   PDB; 6VYB; EM; 3.20 A; A/B/C=14-1211.
DR   PDB; 6W41; X-ray; 3.08 A; C=319-541.
DR   PDB; 6WPS; EM; 3.10 A; A/B/E=11-1211.
DR   PDB; 6WPT; EM; 3.70 A; A/B/C=11-1211.
DR   PDB; 6X29; EM; 2.70 A; A/B/C=16-1208.
DR   PDB; 6X2A; EM; 3.30 A; A/B/C=16-1208.
DR   PDB; 6X2B; EM; 3.60 A; A/B/C=16-1208.
DR   PDB; 6X2C; EM; 3.20 A; A/B/C=16-1208.
DR   PDB; 6X6P; EM; 3.22 A; A/B/C=15-1208.
DR   PDB; 6X79; EM; 2.90 A; A/B/C=14-1211.
DR   PDB; 6XC2; X-ray; 3.11 A; A/Z=319-541.
DR   PDB; 6XC3; X-ray; 2.70 A; C=319-541.
DR   PDB; 6XC4; X-ray; 2.34 A; A/Z=319-541.
DR   PDB; 6XC7; X-ray; 2.88 A; A=319-541.
DR   PDB; 6XCM; EM; 3.42 A; A/B/C=1-1213.
DR   PDB; 6XCN; EM; 3.66 A; A/C/E=1-1213.
DR   PDB; 6XDG; EM; 3.90 A; E=319-541.
DR   PDB; 6XE1; X-ray; 2.75 A; E=319-591.
DR   PDB; 6XEY; EM; 3.25 A; A/B/C=1-1208.
DR   PDB; 6XF5; EM; 3.45 A; A/B/C=14-1208.
DR   PDB; 6XF6; EM; 4.00 A; A/B/C=14-1208.
DR   PDB; 6XKL; EM; 3.21 A; A/B/C=1-1208.
DR   PDB; 6XKP; X-ray; 2.72 A; A/B=319-541.
DR   PDB; 6XKQ; X-ray; 2.55 A; A=319-541.
DR   PDB; 6XLU; EM; 2.40 A; A/B/C=14-1208.
DR   PDB; 6XM0; EM; 2.70 A; A/B/C=14-1208.
DR   PDB; 6XM3; EM; 2.90 A; A/B/C=14-1208.
DR   PDB; 6XM4; EM; 2.90 A; A/B/C=14-1208.
DR   PDB; 6XM5; EM; 3.10 A; A/B/C=14-1208.
DR   PDB; 6XR8; EM; 2.90 A; A/B/C=1-1273.
DR   PDB; 6XRA; EM; 3.00 A; A/B/C=1-1273.
DR   PDB; 6XS6; EM; 3.70 A; A/B/C=1-1213.
DR   PDB; 6YLA; X-ray; 2.42 A; A/E=330-532.
DR   PDB; 6YM0; X-ray; 4.36 A; E=330-532.
DR   PDB; 6YOR; EM; 3.30 A; A/E=330-532.
DR   PDB; 6YZ5; X-ray; 1.80 A; E=330-532.
DR   PDB; 6YZ7; X-ray; 3.30 A; AAA/EEE=330-532.
DR   PDB; 6Z2M; X-ray; 2.71 A; A/E=332-528.
DR   PDB; 6Z43; EM; 3.30 A; A/B/C=1-1208.
DR   PDB; 6Z97; EM; 3.40 A; A/B/C=1-1208.
DR   PDB; 6ZB4; EM; 3.03 A; A/B/C=1-1213.
DR   PDB; 6ZB5; EM; 2.85 A; A/B/C=1-1213.
DR   PDB; 6ZBP; X-ray; 1.85 A; EEE=330-532.
DR   PDB; 6ZCZ; X-ray; 2.65 A; E=333-528.
DR   PDB; 6ZDG; EM; 4.70 A; A/D/E=333-526.
DR   PDB; 6ZDH; EM; 3.70 A; A/B/C=1-1208.
DR   PDB; 6ZER; X-ray; 3.80 A; A/D/E=330-532.
DR   PDB; 6ZFO; EM; 4.40 A; A/E=333-526.
DR   PDB; 6ZGE; EM; 2.60 A; A/B/C=1-1208.
DR   PDB; 6ZGG; EM; 3.80 A; A/B/C=1-1208.
DR   PDB; 6ZGI; EM; 2.90 A; A/B/C=1-1208.
DR   PDB; 6ZH9; X-ray; 3.31 A; EEE=332-528.
DR   PDB; 6ZHD; EM; 3.70 A; A/B/C=1-1208.
DR   PDB; 6ZLR; X-ray; 3.10 A; AAA/DDD/EEE=319-541.
DR   PDB; 6ZOW; EM; 3.00 A; A/B/C/a=1-1273.
DR   PDB; 6ZOX; EM; 3.00 A; A/B/C=14-1211.
DR   PDB; 6ZOY; EM; 3.10 A; A/B/C=14-1211.
DR   PDB; 6ZOZ; EM; 3.50 A; A/B/C=14-1211.
DR   PDB; 6ZP0; EM; 3.00 A; A/B/C=14-1211.
DR   PDB; 6ZP1; EM; 3.30 A; A/B/C=14-1211.
DR   PDB; 6ZP2; EM; 3.10 A; A/B/C=14-1211.
DR   PDB; 6ZP5; EM; 3.10 A; A/B/C=1-1273.
DR   PDB; 6ZP7; EM; 3.30 A; A/B/C=1-1273.
DR   PDB; 6ZWV; EM; 3.50 A; A/B/C=1-1273.
DR   PDB; 6ZXN; EM; 2.93 A; A/B/C=1-1208.
DR   PDB; 7A25; EM; 3.06 A; A/B/C=1-1146.
DR   PDB; 7A29; EM; 2.94 A; A/B/C=1-1208.
DR   PDB; 7A4N; EM; 2.75 A; A/B/C=1-1208.
DR   PDB; 7A5R; EM; 3.70 A; A/B=1-1208.
DR   PDB; 7A5S; EM; 3.90 A; A/B=1-1208.
DR   PDB; 7A91; EM; 3.60 A; A=1-685.
DR   PDB; 7A92; EM; 4.20 A; A=1-676.
DR   PDB; 7A93; EM; 5.90 A; A/B/C=1-1208.
DR   PDB; 7A94; EM; 3.90 A; A/B/C=1-1208.
DR   PDB; 7A95; EM; 4.30 A; A/B/C=1-1208.
DR   PDB; 7A96; EM; 4.80 A; A/B/C=1-1208.
DR   PDB; 7A97; EM; 4.40 A; A/B/C=1-1208.
DR   PDB; 7A98; EM; 5.40 A; A/B/C=1-1208.
DR   PDB; 7AD1; EM; 2.92 A; A/B/C=1-1208.
DR   PDB; 7AKD; EM; 4.00 A; A/B/C=1-1208.
DR   PDB; 7B14; EM; 3.79 A; A=333-528.
DR   PDB; 7B17; EM; 4.01 A; A=334-528.
DR   PDB; 7B18; EM; 2.62 A; A/B/C=1-1208.
DR   PDB; 7B62; X-ray; 1.82 A; A=1-311.
DR   PDB; 7BEH; X-ray; 2.30 A; E=333-528.
DR   PDB; 7BEI; X-ray; 2.30 A; E=333-528.
DR   PDB; 7BEJ; X-ray; 2.42 A; E=333-528.
DR   PDB; 7BEK; X-ray; 2.04 A; E=333-528.
DR   PDB; 7BEL; X-ray; 2.53 A; R/X=333-528.
DR   PDB; 7BEM; X-ray; 2.52 A; E=333-528.
DR   PDB; 7BEN; X-ray; 2.50 A; C/E=333-528.
DR   PDB; 7BEO; X-ray; 3.19 A; R/X=333-528.
DR   PDB; 7BEP; X-ray; 2.61 A; C/E=333-528.
DR   PDB; 7BWJ; X-ray; 2.85 A; E=319-529.
DR   PDB; 7BYR; EM; 3.84 A; A/B/C=1-1208.
DR   PDB; 7BZ5; X-ray; 1.84 A; A=319-541.
DR   PDB; 7C01; X-ray; 2.88 A; A/B=319-541.
DR   PDB; 7C2L; EM; 3.10 A; A/B/C=1-1273.
DR   PDB; 7C53; X-ray; 2.28 A; A/B/C/D/E/F=910-975.
DR   PDB; 7C8D; EM; 3.00 A; B=333-527.
DR   PDB; 7C8J; X-ray; 3.18 A; B=333-527.
DR   PDB; 7C8V; X-ray; 2.15 A; B=330-531.
DR   PDB; 7C8W; X-ray; 2.77 A; B=330-531.
DR   PDB; 7CAB; EM; 3.52 A; A/B/C=1-1208.
DR   PDB; 7CAC; EM; 3.55 A; A/B/C=1-1208.
DR   PDB; 7CAH; EM; 3.90 A; A=334-527.
DR   PDB; 7CAI; EM; 3.49 A; A/B/C=1-1208.
DR   PDB; 7CAK; EM; 3.58 A; A/B/C=1-1208.
DR   PDB; 7CAN; X-ray; 2.94 A; B=330-531.
DR   PDB; 7CDI; X-ray; 2.96 A; E=319-529.
DR   PDB; 7CDJ; X-ray; 3.40 A; E=319-529.
DR   PDB; 7CH4; X-ray; 3.15 A; R=319-541.
DR   PDB; 7CH5; X-ray; 2.70 A; R=319-541.
DR   PDB; 7CHB; X-ray; 2.40 A; R=319-541.
DR   PDB; 7CHC; X-ray; 2.71 A; R=319-541.
DR   PDB; 7CHE; X-ray; 3.42 A; R=319-541.
DR   PDB; 7CHF; X-ray; 2.67 A; R=319-541.
DR   PDB; 7CHH; EM; 3.49 A; A/B/C=1-1208.
DR   PDB; 7CHO; X-ray; 2.56 A; A/E=319-529.
DR   PDB; 7CHP; X-ray; 2.36 A; E=319-529.
DR   PDB; 7CHS; X-ray; 2.40 A; E=319-529.
DR   PDB; 7CJF; X-ray; 2.11 A; C=334-527.
DR   PDB; 7CM4; X-ray; 2.71 A; A=319-536.
DR   PDB; 7CN4; EM; 2.93 A; A/B/C=1-1213.
DR   PDB; 7CN9; EM; 4.70 A; A/B/C=14-1140.
DR   PDB; 7CT5; EM; 4.00 A; A/B/C=1-1273.
DR   PDB; 7CWL; EM; 3.80 A; A/B/C=1-1273.
DR   PDB; 7CWM; EM; 3.60 A; A/B/C=1-1273.
DR   PDB; 7CWN; EM; 3.20 A; A/B/C=1-1273.
DR   PDB; 7CWO; EM; 3.90 A; A=1-1273.
DR   PDB; 7CWS; EM; 3.40 A; O/Q/R=14-1147.
DR   PDB; 7CWT; EM; 3.70 A; A/B/C=14-1147.
DR   PDB; 7CWU; EM; 3.50 A; A/B/C=1-1273.
DR   PDB; 7CYH; EM; 3.90 A; A=334-527.
DR   PDB; 7CYP; EM; 3.50 A; A/B/C=1-1208.
DR   PDB; 7CZP; EM; 3.00 A; A/B/C=1-1273.
DR   PDB; 7CZQ; EM; 2.80 A; A/B/C=1-1273.
DR   PDB; 7CZR; EM; 3.50 A; A/B/C=1-1273.
DR   PDB; 7CZS; EM; 3.60 A; A/B/C=1-1273.
DR   PDB; 7CZT; EM; 2.70 A; A/B/C=1-1273.
DR   PDB; 7CZU; EM; 3.40 A; A/B/C=1-1273.
DR   PDB; 7CZV; EM; 3.30 A; A/B/C=1-1273.
DR   PDB; 7CZW; EM; 2.80 A; A/B/C=1-1273.
DR   PDB; 7CZX; EM; 2.80 A; A/B/C=1-1273.
DR   PDB; 7CZY; EM; 3.30 A; A/B/C=1-1273.
DR   PDB; 7CZZ; EM; 3.20 A; A/B/C=1-1273.
DR   PDB; 7D00; EM; 3.00 A; A/B/C=1-1273.
DR   PDB; 7D03; EM; 3.20 A; A/B/C=1-1273.
DR   PDB; 7D0B; EM; 3.90 A; A/B/C=1-1273.
DR   PDB; 7D0C; EM; 3.40 A; A/B/C=1-1273.
DR   PDB; 7D0D; EM; 3.80 A; A/B/C=1-1273.
DR   PDB; 7D2Z; X-ray; 1.97 A; B=330-531.
DR   PDB; 7D30; X-ray; 2.10 A; B=330-531.
DR   PDB; 7D4G; EM; 3.90 A; B=13-290.
DR   PDB; 7DCC; EM; 4.30 A; E/I/K=1-1208.
DR   PDB; 7DCX; EM; 5.90 A; C/D/K=1-1208.
DR   PDB; 7DD2; EM; 5.60 A; C/D/K=1-1208.
DR   PDB; 7DD8; EM; 7.50 A; C/D/E=1-1208.
DR   PDB; 7DDD; EM; 3.00 A; A/B/C=1-1208.
DR   PDB; 7DDN; EM; 6.30 A; A/B/C=1-1208.
DR   PDB; 7DEO; X-ray; 2.50 A; B/D=334-530.
DR   PDB; 7DET; X-ray; 2.20 A; A/C=334-530.
DR   PDB; 7DEU; X-ray; 2.10 A; A=334-530.
DR   PDB; 7DF3; EM; 2.70 A; A/B/C=1-1208.
DR   PDB; 7DF4; EM; 3.80 A; B/C/D=1-1208.
DR   PDB; 7DJZ; X-ray; 2.40 A; C=319-541.
DR   PDB; 7DK0; X-ray; 3.20 A; C=319-541.
DR   PDB; 7DK3; EM; 6.00 A; A/B/C=1-1208.
DR   PDB; 7DK4; EM; 3.80 A; A/B/C=1-1208.
DR   PDB; 7DK5; EM; 13.50 A; A/B/C=1-1208.
DR   PDB; 7DK6; EM; 4.30 A; A/B/C=1-1208.
DR   PDB; 7DK7; EM; 9.70 A; A/B/C=1-1208.
DR   PDB; 7DMU; X-ray; 3.20 A; B/D=319-531.
DR   PDB; 7DPM; X-ray; 3.30 A; C/F/I/L=319-541.
DR   PDB; 7DWX; EM; 8.30 A; E/F/G/H/I/J=1-1273.
DR   PDB; 7DWY; EM; 2.70 A; A/B/C=1-1273.
DR   PDB; 7DWZ; EM; 3.30 A; A/B/C=1-1273.
DR   PDB; 7DX0; EM; 3.20 A; A/B/C=1-1273.
DR   PDB; 7DX1; EM; 3.10 A; A/B/C=1-1273.
DR   PDB; 7DX2; EM; 3.30 A; A/B/C=1-1273.
DR   PDB; 7DX3; EM; 3.50 A; A/B/C=1-1273.
DR   PDB; 7DX4; EM; 3.60 A; E=333-526.
DR   PDB; 7DX5; EM; 3.30 A; A/B/C=1-1273.
DR   PDB; 7DX6; EM; 3.00 A; A/B/C=1-1273.
DR   PDB; 7DX7; EM; 3.40 A; A/B/C=1-1273.
DR   PDB; 7DX8; EM; 2.90 A; A/B/C=1-1273.
DR   PDB; 7DX9; EM; 3.60 A; A/B/C=1-1273.
DR   PDB; 7DZW; EM; 3.45 A; A/B/C=14-1254.
DR   PDB; 7DZX; EM; 3.53 A; A/B/C=27-1147.
DR   PDB; 7DZY; EM; 3.60 A; A/B/C=27-1211.
DR   PDB; 7E23; EM; 3.30 A; A=333-526.
DR   PDB; 7E3J; X-ray; 2.99 A; B=333-527.
DR   PDB; 7E5Y; X-ray; 3.59 A; A/R=319-541.
DR   PDB; 7E7B; EM; 2.60 A; A/B/C=1-1211.
DR   PDB; 7E7D; EM; 3.20 A; A/B/C=1-1211.
DR   PDB; 7E7X; X-ray; 2.78 A; A/B=13-303.
DR   PDB; 7E7Y; X-ray; 2.41 A; E/R=319-541.
DR   PDB; 7E86; X-ray; 2.90 A; C=333-526.
DR   PDB; 7E88; X-ray; 3.14 A; C/F/I/L=333-526.
DR   PDB; 7E8C; EM; 3.16 A; A/B/C=1-1208.
DR   PDB; 7E8F; EM; 3.18 A; A=13-303, R=319-541.
DR   PDB; 7E8M; X-ray; 2.09 A; E=333-527.
DR   PDB; 7EAM; X-ray; 1.40 A; A/B=319-541.
DR   PDB; 7EAN; X-ray; 1.91 A; A=319-541.
DR   PDB; 7EAZ; EM; 3.50 A; A/B/C=1-1208.
DR   PDB; 7EB0; EM; 3.60 A; A/B/C=1-1208.
DR   PDB; 7EB3; EM; 3.60 A; A/B/C=1-1208.
DR   PDB; 7EB4; EM; 3.50 A; A/B/C=1-1208.
DR   PDB; 7EB5; EM; 3.40 A; A/B/C=1-1208.
DR   PDB; 7EJ4; EM; 3.60 A; A/B/C=1-1208.
DR   PDB; 7EJ5; EM; 3.50 A; A/B/C=1-1208.
DR   PDB; 7EK6; X-ray; 1.24 A; A=906-957, B=1175-1211.
DR   PDB; 7JJC; X-ray; 2.36 A; E/F/G/H=679-685.
DR   PDB; 7JJI; EM; 3.60 A; A/B/C=1-1273.
DR   PDB; 7JJJ; EM; 4.50 A; A/B/C/D/E/F=1-1273.
DR   PDB; 7JMO; X-ray; 2.36 A; A=319-541.
DR   PDB; 7JMP; X-ray; 1.71 A; A=319-541.
DR   PDB; 7JMW; X-ray; 2.89 A; A=319-541.
DR   PDB; 7JV2; EM; 3.50 A; A=14-1211.
DR   PDB; 7JV4; EM; 3.40 A; A/B/C=14-1211.
DR   PDB; 7JV6; EM; 3.00 A; A/B/E=14-1211.
DR   PDB; 7JVA; EM; 3.60 A; A=14-1211.
DR   PDB; 7JVB; X-ray; 3.29 A; A/B=319-541.
DR   PDB; 7JVC; EM; 3.30 A; A/B/E=14-1211.
DR   PDB; 7JW0; EM; 4.30 A; A/B/E=14-1211.
DR   PDB; 7JWB; EM; 6.00 A; A/B/C=1-1208.
DR   PDB; 7JWY; EM; 2.50 A; A/B/C=14-1208.
DR   PDB; 7JX3; X-ray; 2.65 A; R=328-531.
DR   PDB; 7JZL; EM; 2.70 A; A/B/C=1-1208.
DR   PDB; 7JZM; EM; 3.50 A; B=1-1208.
DR   PDB; 7JZN; EM; 3.10 A; A/B/C=1-1208.
DR   PDB; 7JZU; EM; 3.10 A; B=1-1208.
DR   PDB; 7K43; EM; 2.60 A; A/B/E=14-1211.
DR   PDB; 7K45; EM; 3.70 A; B=1-1208.
DR   PDB; 7K4N; EM; 3.30 A; A/B/E=1-1208.
DR   PDB; 7K8M; X-ray; 3.20 A; E=331-517.
DR   PDB; 7K8S; EM; 3.40 A; A/B/C=1-1213.
DR   PDB; 7K8T; EM; 3.40 A; A/B/C=1-1213.
DR   PDB; 7K8U; EM; 3.80 A; A/B/C=1-1213.
DR   PDB; 7K8V; EM; 3.80 A; A/B/C=1-1213.
DR   PDB; 7K8W; EM; 3.60 A; A/B/G=1-1213.
DR   PDB; 7K8X; EM; 3.90 A; A/B/C=1-1213.
DR   PDB; 7K8Y; EM; 4.40 A; B/D/E=1-1213.
DR   PDB; 7K8Z; EM; 3.50 A; A/B/C=1-1213.
DR   PDB; 7K90; EM; 3.24 A; A/B/C=1-1208.
DR   PDB; 7K9Z; X-ray; 2.95 A; E=319-541.
DR   PDB; 7KDG; EM; 3.01 A; A/B/C=1-1208.
DR   PDB; 7KDH; EM; 3.33 A; A/B/C=1-1208.
DR   PDB; 7KDI; EM; 3.26 A; A/B/C=1-1208.
DR   PDB; 7KDJ; EM; 3.49 A; A/B/C=1-1208.
DR   PDB; 7KDK; EM; 2.80 A; A/B/C=1-1208.
DR   PDB; 7KDL; EM; 2.96 A; A/B/C=1-1208.
DR   PDB; 7KE4; EM; 3.21 A; A/B/C=1-1208.
DR   PDB; 7KE6; EM; 3.10 A; A/B/C=1-1208.
DR   PDB; 7KE7; EM; 3.32 A; A/B/C=1-1208.
DR   PDB; 7KE8; EM; 3.26 A; A/B/C=1-1208.
DR   PDB; 7KE9; EM; 3.08 A; A/B/C=1-1208.
DR   PDB; 7KEA; EM; 3.33 A; A/B/C=1-1208.
DR   PDB; 7KEB; EM; 3.48 A; A/B/C=1-1208.
DR   PDB; 7KEC; EM; 3.84 A; A/B/C=1-1208.
DR   PDB; 7KFV; X-ray; 2.10 A; A/B/E=319-541.
DR   PDB; 7KFW; X-ray; 2.79 A; A/B/E=319-541.
DR   PDB; 7KFX; X-ray; 2.23 A; A=319-541.
DR   PDB; 7KFY; X-ray; 2.16 A; A=319-541.
DR   PDB; 7KGJ; X-ray; 2.30 A; A=333-528.
DR   PDB; 7KGK; X-ray; 2.60 A; A=333-527.
DR   PDB; 7KJ2; EM; 3.60 A; A/B/C=14-1208.
DR   PDB; 7KJ3; EM; 3.70 A; A/B/C=14-1208.
DR   PDB; 7KJ4; EM; 3.40 A; A/B/C=14-1208.
DR   PDB; 7KJ5; EM; 3.60 A; A/B/C=14-1208.
DR   PDB; 7KKK; EM; 3.03 A; A/C/E=1-1208.
DR   PDB; 7KKL; EM; 2.85 A; A/C/D=1-1208.
DR   PDB; 7KL9; EM; 4.10 A; A/B/C=1-1208.
DR   PDB; 7KLG; X-ray; 3.20 A; A/B=328-528.
DR   PDB; 7KLH; X-ray; 3.00 A; A/B=328-528.
DR   PDB; 7KLW; X-ray; 2.60 A; A=334-527.
DR   PDB; 7KMB; EM; 3.39 A; G=16-1208.
DR   PDB; 7KMG; X-ray; 2.16 A; C/F=329-527.
DR   PDB; 7KMH; X-ray; 1.72 A; C=329-527.
DR   PDB; 7KMI; X-ray; 1.73 A; C=329-527.
DR   PDB; 7KMK; EM; 4.20 A; A/B/C=1-1211.
DR   PDB; 7KML; EM; 3.80 A; A/B/C=1-1211.
DR   PDB; 7KMS; EM; 3.64 A; A/B/C=1-1208.
DR   PDB; 7KMZ; EM; 3.62 A; A/B/C=1-1208.
DR   PDB; 7KN5; X-ray; 1.87 A; A/B=319-541.
DR   PDB; 7KN6; X-ray; 2.55 A; A=319-541.
DR   PDB; 7KN7; X-ray; 2.73 A; A=319-541.
DR   PDB; 7KNB; EM; 3.93 A; A/B/C=1-1208.
DR   PDB; 7KNE; EM; 3.85 A; A/B/C=1-1208.
DR   PDB; 7KNH; EM; 3.74 A; A/B/C=1-1208.
DR   PDB; 7KNI; EM; 3.91 A; A/B/C=1-1208.
DR   PDB; 7KQB; EM; 2.42 A; A/B/C=1-1208.
DR   PDB; 7KQE; EM; 2.88 A; A/B/C=1-1208.
DR   PDB; 7KRQ; EM; 3.44 A; A/B/C=1-1273.
DR   PDB; 7KRR; EM; 3.50 A; A/B/C=1-1273.
DR   PDB; 7KRS; EM; 3.20 A; A/B/C=1-1273.
DR   PDB; 7KS9; EM; 4.75 A; A/B/C=1-1208.
DR   PDB; 7KSG; EM; 3.33 A; A/B/C=1-1208.
DR   PDB; 7KXJ; EM; 6.40 A; A/B/C=1-1211.
DR   PDB; 7KXK; EM; 5.00 A; A/B/C=1-1211.
DR   PDB; 7KZB; X-ray; 2.83 A; C=333-528.
DR   PDB; 7L02; EM; 3.20 A; A/B/C=27-1147.
DR   PDB; 7L06; EM; 3.30 A; A/B/C=27-1147.
DR   PDB; 7L09; EM; 3.10 A; A/B/C=27-1147.
DR   PDB; 7L0N; X-ray; 2.78 A; R/S=328-531.
DR   PDB; 7L2C; X-ray; 3.65 A; A/B=1-334.
DR   PDB; 7L2D; EM; 3.55 A; A/B/C=1-1208.
DR   PDB; 7L2E; EM; 2.97 A; A/B/C=1-1208.
DR   PDB; 7L2F; EM; 3.90 A; A/B/C=1-1208.
DR   PDB; 7L3N; EM; 3.27 A; A/B/C=13-1208.
DR   PDB; 7L4Z; X-ray; 3.96 A; A/B/C/D/E=319-541.
DR   PDB; 7L56; EM; 3.60 A; A/B/C=1-1208.
DR   PDB; 7L57; EM; 5.87 A; A/B/C=1-1208.
DR   PDB; 7L58; EM; 5.07 A; A/B/C=1-1208.
DR   PDB; 7L5B; X-ray; 3.18 A; A=319-537.
DR   PDB; 7L7F; EM; 3.24 A; E/F=323-528.
DR   PDB; 7L7K; EM; 3.29 A; A/B/C=1-1273.
DR   PDB; 7LAA; EM; 3.42 A; A/B/C=27-1147.
DR   PDB; 7LAB; EM; 2.97 A; A/B/C=27-1147.
DR   PDB; 7LC8; NMR; -; A/B/C=1217-1237.
DR   PDB; 7LCN; EM; 3.35 A; A/C/K=27-1147.
DR   PDB; 7LD1; EM; 3.40 A; A/B/C=27-1147.
DR   PDB; 7LDJ; X-ray; 2.36 A; A/B/C/D=331-527.
DR   PDB; 7LJR; EM; 3.66 A; A/B/C=1-1208.
DR   PDB; 7LM8; X-ray; 1.94 A; A=319-541.
DR   PDB; 7LO4; X-ray; 2.46 A; B=333-530.
DR   PDB; 7LOP; X-ray; 2.25 A; A/Z=319-541.
DR   PDB; 7LQV; EM; 3.25 A; A/B/C=14-1208.
DR   PDB; 7LQW; EM; 4.47 A; A/B/C=14-1208.
DR   PDB; 7LS9; EM; 3.42 A; A/B/C=1-1208.
DR   PDB; 7LSS; EM; 3.72 A; A/B/C=1-1208.
DR   PDB; 7LWI; EM; 3.07 A; A/B/C=1-1208.
DR   PDB; 7LWJ; EM; 3.24 A; A/B/C=1-1208.
DR   PDB; 7LWK; EM; 2.92 A; A/B/C=1-1208.
DR   PDB; 7LWL; EM; 2.84 A; A/B/C=1-1208.
DR   PDB; 7LWM; EM; 2.83 A; A/B/C=1-1208.
DR   PDB; 7LWN; EM; 2.94 A; A/B/C=1-1208.
DR   PDB; 7LWO; EM; 2.85 A; A/B/C=1-1208.
DR   PDB; 7LWP; EM; 3.01 A; A/B/C=1-1208.
DR   PDB; 7LWQ; EM; 3.44 A; A/B/C=1-1208.
DR   PDB; 7LWS; EM; 3.22 A; A/B/C=1-1208.
DR   PDB; 7LWT; EM; 3.19 A; A/B/C=1-1208.
DR   PDB; 7LWU; EM; 3.22 A; A/B/C=1-1208.
DR   PDB; 7LWV; EM; 3.12 A; A/B/C=1-1208.
DR   PDB; 7LWW; EM; 3.00 A; A/B/C=1-1208.
DR   PDB; 7LX5; EM; 3.44 A; B=1-1208.
DR   PDB; 7LXW; EM; 2.80 A; A=1-1208.
DR   PDB; 7LXX; EM; 3.00 A; A=1-1208.
DR   PDB; 7LXY; EM; 2.20 A; A/B/J=1-1208.
DR   PDB; 7LXZ; EM; 2.60 A; A/B/K=1-1208.
DR   PDB; 7LY0; EM; 2.60 A; A=1-1208.
DR   PDB; 7LY2; EM; 2.50 A; A/B/J=1-1208.
DR   PDB; 7LY3; X-ray; 3.00 A; A/B=14-307.
DR   PDB; 7LYK; EM; 3.65 A; A/B/C=1-1208.
DR   PDB; 7LYL; EM; 3.72 A; A/B/C=1-1208.
DR   PDB; 7LYM; EM; 3.57 A; A/B/C=1-1208.
DR   PDB; 7LYN; EM; 3.32 A; A/B/C=1-1208.
DR   PDB; 7LYO; EM; 3.32 A; A/B/C=1-1208.
DR   PDB; 7LYP; EM; 4.05 A; A/B/C=1-1208.
DR   PDB; 7LYQ; EM; 3.34 A; A/B/C=1-1208.
DR   PDB; 7M0J; EM; 3.52 A; A/B/C=16-1208.
DR   PDB; 7M3I; X-ray; 2.80 A; C/R=319-591.
DR   PDB; 7M53; X-ray; 1.40 A; A=1146-1161.
DR   PDB; 7M6D; X-ray; 3.10 A; C=328-533.
DR   PDB; 7M6E; EM; 3.30 A; A/B/E=1-1208.
DR   PDB; 7M6F; EM; 3.90 A; A/B/E=1-1208.
DR   PDB; 7M6G; EM; 3.70 A; A/B/C=1-1208.
DR   PDB; 7M6H; EM; 4.00 A; A/B/C=1-1213.
DR   PDB; 7M6I; EM; 4.00 A; A/B/C=1-1213.
DR   PDB; 7M71; EM; 2.66 A; A/B=1-1208.
DR   PDB; 7M7B; EM; 2.95 A; A=1-1208.
DR   PDB; 7M7W; X-ray; 2.65 A; R/S=328-531.
DR   PDB; 7M8J; EM; 3.48 A; A=14-270.
DR   PDB; 7M8K; EM; -; A/B/C=1-1208.
DR   PDB; 7M8S; X-ray; 2.35 A; C/F=386-395.
DR   PDB; 7M8T; X-ray; 1.50 A; C=370-378.
DR   PDB; 7M8U; X-ray; 1.45 A; C=896-904.
DR   PDB; 7MF1; X-ray; 2.09 A; A=333-530.
DR   PDB; 7MFU; X-ray; 1.70 A; A/D=332-528.
DR   PDB; 7MJG; EM; 2.81 A; A/B/C=1-1208.
DR   PDB; 7MJH; EM; 2.66 A; A/B/C=1-1208.
DR   PDB; 7MJI; EM; 2.81 A; B=1-1208.
DR   PDB; 7MJJ; EM; 3.32 A; A/B/C=1-1208.
DR   PDB; 7MJK; EM; 2.73 A; A/B/C=1-1208.
DR   PDB; 7MJL; EM; 2.95 A; A=1-1208.
DR   PDB; 7MJM; EM; 2.83 A; A/B/C=1-1208.
DR   PDB; 7MJN; EM; 3.29 A; B=1-1208.
DR   PDB; 7MKB; X-ray; 1.90 A; C=269-277.
DR   PDB; 7MKL; EM; 3.20 A; A/B/C=27-1147.
DR   PDB; 7MKM; EM; 3.16 A; A=333-520.
DR   PDB; 7MMO; X-ray; 2.43 A; C/F=329-527.
DR   PDB; 7MY2; EM; 2.65 A; B/C/E=1-1208.
DR   PDB; 7MY3; EM; 2.90 A; A/B/C=1-1208.
DR   PDB; 7N0G; EM; 3.02 A; A/B/C=1-1208.
DR   PDB; 7N0H; EM; 3.34 A; A/B/C=1-1208.
DR   PDB; 7ND3; EM; 3.70 A; A/B/C=1-1208.
DR   PDB; 7ND4; EM; 3.60 A; A/B/C=1-1208.
DR   PDB; 7ND5; EM; 3.40 A; A/B/C=1-1208.
DR   PDB; 7ND6; EM; 7.30 A; A/B/C=1-1208.
DR   PDB; 7ND7; EM; 3.60 A; A/B/C=1-1208.
DR   PDB; 7ND8; EM; 3.50 A; A/B/C=1-1208.
DR   PDB; 7ND9; EM; 2.80 A; A/B/C=1-1208.
DR   PDB; 7NDA; EM; 3.30 A; A/B/C=1-1208.
DR   PDB; 7NDB; EM; 4.60 A; A/B/C=1-1208.
DR   PDB; 7NDC; EM; 4.10 A; A/B/C=1-1208.
DR   PDB; 7NDD; EM; 4.20 A; A/B/C=1-1208.
DR   PDB; 7NEG; X-ray; 2.19 A; E=333-528.
DR   PDB; 7NEH; X-ray; 1.77 A; E=333-528.
DR   PDB; 7NKT; X-ray; 2.30 A; AAA=319-541.
DR   PDB; 7NT9; EM; 3.36 A; A/B/C=1-1208.
DR   PDB; 7NTA; EM; 3.50 A; A/B/C=1-1208.
DR   PDB; 7NTC; EM; 3.60 A; A/B/C=1-1208.
DR   PDB; 7NX6; X-ray; 2.25 A; E=333-528.
DR   PDB; 7NX7; X-ray; 2.30 A; E=333-528.
DR   PDB; 7NX8; X-ray; 1.95 A; E=333-528.
DR   PDB; 7NX9; X-ray; 2.40 A; E=333-528.
DR   PDB; 7NXA; X-ray; 2.50 A; E=333-528.
DR   PDB; 7NXB; X-ray; 2.67 A; E=333-528.
DR   PDB; 7NXC; X-ray; 3.14 A; B=333-528.
DR   PDBsum; 6LVN; -.
DR   PDBsum; 6LXT; -.
DR   PDBsum; 6LZG; -.
DR   PDBsum; 6M0J; -.
DR   PDBsum; 6M17; -.
DR   PDBsum; 6M1V; -.
DR   PDBsum; 6VSB; -.
DR   PDBsum; 6VW1; -.
DR   PDBsum; 6VXX; -.
DR   PDBsum; 6VYB; -.
DR   PDBsum; 6W41; -.
DR   PDBsum; 6WPS; -.
DR   PDBsum; 6WPT; -.
DR   PDBsum; 6X29; -.
DR   PDBsum; 6X2A; -.
DR   PDBsum; 6X2B; -.
DR   PDBsum; 6X2C; -.
DR   PDBsum; 6X6P; -.
DR   PDBsum; 6X79; -.
DR   PDBsum; 6XC2; -.
DR   PDBsum; 6XC3; -.
DR   PDBsum; 6XC4; -.
DR   PDBsum; 6XC7; -.
DR   PDBsum; 6XCM; -.
DR   PDBsum; 6XCN; -.
DR   PDBsum; 6XDG; -.
DR   PDBsum; 6XE1; -.
DR   PDBsum; 6XEY; -.
DR   PDBsum; 6XF5; -.
DR   PDBsum; 6XF6; -.
DR   PDBsum; 6XKL; -.
DR   PDBsum; 6XKP; -.
DR   PDBsum; 6XKQ; -.
DR   PDBsum; 6XLU; -.
DR   PDBsum; 6XM0; -.
DR   PDBsum; 6XM3; -.
DR   PDBsum; 6XM4; -.
DR   PDBsum; 6XM5; -.
DR   PDBsum; 6XR8; -.
DR   PDBsum; 6XRA; -.
DR   PDBsum; 6XS6; -.
DR   PDBsum; 6YLA; -.
DR   PDBsum; 6YM0; -.
DR   PDBsum; 6YOR; -.
DR   PDBsum; 6YZ5; -.
DR   PDBsum; 6YZ7; -.
DR   PDBsum; 6Z2M; -.
DR   PDBsum; 6Z43; -.
DR   PDBsum; 6Z97; -.
DR   PDBsum; 6ZB4; -.
DR   PDBsum; 6ZB5; -.
DR   PDBsum; 6ZBP; -.
DR   PDBsum; 6ZCZ; -.
DR   PDBsum; 6ZDG; -.
DR   PDBsum; 6ZDH; -.
DR   PDBsum; 6ZER; -.
DR   PDBsum; 6ZFO; -.
DR   PDBsum; 6ZGE; -.
DR   PDBsum; 6ZGG; -.
DR   PDBsum; 6ZGI; -.
DR   PDBsum; 6ZH9; -.
DR   PDBsum; 6ZHD; -.
DR   PDBsum; 6ZLR; -.
DR   PDBsum; 6ZOW; -.
DR   PDBsum; 6ZOX; -.
DR   PDBsum; 6ZOY; -.
DR   PDBsum; 6ZOZ; -.
DR   PDBsum; 6ZP0; -.
DR   PDBsum; 6ZP1; -.
DR   PDBsum; 6ZP2; -.
DR   PDBsum; 6ZP5; -.
DR   PDBsum; 6ZP7; -.
DR   PDBsum; 6ZWV; -.
DR   PDBsum; 6ZXN; -.
DR   PDBsum; 7A25; -.
DR   PDBsum; 7A29; -.
DR   PDBsum; 7A4N; -.
DR   PDBsum; 7A5R; -.
DR   PDBsum; 7A5S; -.
DR   PDBsum; 7A91; -.
DR   PDBsum; 7A92; -.
DR   PDBsum; 7A93; -.
DR   PDBsum; 7A94; -.
DR   PDBsum; 7A95; -.
DR   PDBsum; 7A96; -.
DR   PDBsum; 7A97; -.
DR   PDBsum; 7A98; -.
DR   PDBsum; 7AD1; -.
DR   PDBsum; 7AKD; -.
DR   PDBsum; 7B14; -.
DR   PDBsum; 7B17; -.
DR   PDBsum; 7B18; -.
DR   PDBsum; 7B62; -.
DR   PDBsum; 7BEH; -.
DR   PDBsum; 7BEI; -.
DR   PDBsum; 7BEJ; -.
DR   PDBsum; 7BEK; -.
DR   PDBsum; 7BEL; -.
DR   PDBsum; 7BEM; -.
DR   PDBsum; 7BEN; -.
DR   PDBsum; 7BEO; -.
DR   PDBsum; 7BEP; -.
DR   PDBsum; 7BWJ; -.
DR   PDBsum; 7BYR; -.
DR   PDBsum; 7BZ5; -.
DR   PDBsum; 7C01; -.
DR   PDBsum; 7C2L; -.
DR   PDBsum; 7C53; -.
DR   PDBsum; 7C8D; -.
DR   PDBsum; 7C8J; -.
DR   PDBsum; 7C8V; -.
DR   PDBsum; 7C8W; -.
DR   PDBsum; 7CAB; -.
DR   PDBsum; 7CAC; -.
DR   PDBsum; 7CAH; -.
DR   PDBsum; 7CAI; -.
DR   PDBsum; 7CAK; -.
DR   PDBsum; 7CAN; -.
DR   PDBsum; 7CDI; -.
DR   PDBsum; 7CDJ; -.
DR   PDBsum; 7CH4; -.
DR   PDBsum; 7CH5; -.
DR   PDBsum; 7CHB; -.
DR   PDBsum; 7CHC; -.
DR   PDBsum; 7CHE; -.
DR   PDBsum; 7CHF; -.
DR   PDBsum; 7CHH; -.
DR   PDBsum; 7CHO; -.
DR   PDBsum; 7CHP; -.
DR   PDBsum; 7CHS; -.
DR   PDBsum; 7CJF; -.
DR   PDBsum; 7CM4; -.
DR   PDBsum; 7CN4; -.
DR   PDBsum; 7CN9; -.
DR   PDBsum; 7CT5; -.
DR   PDBsum; 7CWL; -.
DR   PDBsum; 7CWM; -.
DR   PDBsum; 7CWN; -.
DR   PDBsum; 7CWO; -.
DR   PDBsum; 7CWS; -.
DR   PDBsum; 7CWT; -.
DR   PDBsum; 7CWU; -.
DR   PDBsum; 7CYH; -.
DR   PDBsum; 7CYP; -.
DR   PDBsum; 7CZP; -.
DR   PDBsum; 7CZQ; -.
DR   PDBsum; 7CZR; -.
DR   PDBsum; 7CZS; -.
DR   PDBsum; 7CZT; -.
DR   PDBsum; 7CZU; -.
DR   PDBsum; 7CZV; -.
DR   PDBsum; 7CZW; -.
DR   PDBsum; 7CZX; -.
DR   PDBsum; 7CZY; -.
DR   PDBsum; 7CZZ; -.
DR   PDBsum; 7D00; -.
DR   PDBsum; 7D03; -.
DR   PDBsum; 7D0B; -.
DR   PDBsum; 7D0C; -.
DR   PDBsum; 7D0D; -.
DR   PDBsum; 7D2Z; -.
DR   PDBsum; 7D30; -.
DR   PDBsum; 7D4G; -.
DR   PDBsum; 7DCC; -.
DR   PDBsum; 7DCX; -.
DR   PDBsum; 7DD2; -.
DR   PDBsum; 7DD8; -.
DR   PDBsum; 7DDD; -.
DR   PDBsum; 7DDN; -.
DR   PDBsum; 7DEO; -.
DR   PDBsum; 7DET; -.
DR   PDBsum; 7DEU; -.
DR   PDBsum; 7DF3; -.
DR   PDBsum; 7DF4; -.
DR   PDBsum; 7DJZ; -.
DR   PDBsum; 7DK0; -.
DR   PDBsum; 7DK3; -.
DR   PDBsum; 7DK4; -.
DR   PDBsum; 7DK5; -.
DR   PDBsum; 7DK6; -.
DR   PDBsum; 7DK7; -.
DR   PDBsum; 7DMU; -.
DR   PDBsum; 7DPM; -.
DR   PDBsum; 7DWX; -.
DR   PDBsum; 7DWY; -.
DR   PDBsum; 7DWZ; -.
DR   PDBsum; 7DX0; -.
DR   PDBsum; 7DX1; -.
DR   PDBsum; 7DX2; -.
DR   PDBsum; 7DX3; -.
DR   PDBsum; 7DX4; -.
DR   PDBsum; 7DX5; -.
DR   PDBsum; 7DX6; -.
DR   PDBsum; 7DX7; -.
DR   PDBsum; 7DX8; -.
DR   PDBsum; 7DX9; -.
DR   PDBsum; 7DZW; -.
DR   PDBsum; 7DZX; -.
DR   PDBsum; 7DZY; -.
DR   PDBsum; 7E23; -.
DR   PDBsum; 7E3J; -.
DR   PDBsum; 7E5Y; -.
DR   PDBsum; 7E7B; -.
DR   PDBsum; 7E7D; -.
DR   PDBsum; 7E7X; -.
DR   PDBsum; 7E7Y; -.
DR   PDBsum; 7E86; -.
DR   PDBsum; 7E88; -.
DR   PDBsum; 7E8C; -.
DR   PDBsum; 7E8F; -.
DR   PDBsum; 7E8M; -.
DR   PDBsum; 7EAM; -.
DR   PDBsum; 7EAN; -.
DR   PDBsum; 7EAZ; -.
DR   PDBsum; 7EB0; -.
DR   PDBsum; 7EB3; -.
DR   PDBsum; 7EB4; -.
DR   PDBsum; 7EB5; -.
DR   PDBsum; 7EJ4; -.
DR   PDBsum; 7EJ5; -.
DR   PDBsum; 7EK6; -.
DR   PDBsum; 7JJC; -.
DR   PDBsum; 7JJI; -.
DR   PDBsum; 7JJJ; -.
DR   PDBsum; 7JMO; -.
DR   PDBsum; 7JMP; -.
DR   PDBsum; 7JMW; -.
DR   PDBsum; 7JV2; -.
DR   PDBsum; 7JV4; -.
DR   PDBsum; 7JV6; -.
DR   PDBsum; 7JVA; -.
DR   PDBsum; 7JVB; -.
DR   PDBsum; 7JVC; -.
DR   PDBsum; 7JW0; -.
DR   PDBsum; 7JWB; -.
DR   PDBsum; 7JWY; -.
DR   PDBsum; 7JX3; -.
DR   PDBsum; 7JZL; -.
DR   PDBsum; 7JZM; -.
DR   PDBsum; 7JZN; -.
DR   PDBsum; 7JZU; -.
DR   PDBsum; 7K43; -.
DR   PDBsum; 7K45; -.
DR   PDBsum; 7K4N; -.
DR   PDBsum; 7K8M; -.
DR   PDBsum; 7K8S; -.
DR   PDBsum; 7K8T; -.
DR   PDBsum; 7K8U; -.
DR   PDBsum; 7K8V; -.
DR   PDBsum; 7K8W; -.
DR   PDBsum; 7K8X; -.
DR   PDBsum; 7K8Y; -.
DR   PDBsum; 7K8Z; -.
DR   PDBsum; 7K90; -.
DR   PDBsum; 7K9Z; -.
DR   PDBsum; 7KDG; -.
DR   PDBsum; 7KDH; -.
DR   PDBsum; 7KDI; -.
DR   PDBsum; 7KDJ; -.
DR   PDBsum; 7KDK; -.
DR   PDBsum; 7KDL; -.
DR   PDBsum; 7KE4; -.
DR   PDBsum; 7KE6; -.
DR   PDBsum; 7KE7; -.
DR   PDBsum; 7KE8; -.
DR   PDBsum; 7KE9; -.
DR   PDBsum; 7KEA; -.
DR   PDBsum; 7KEB; -.
DR   PDBsum; 7KEC; -.
DR   PDBsum; 7KFV; -.
DR   PDBsum; 7KFW; -.
DR   PDBsum; 7KFX; -.
DR   PDBsum; 7KFY; -.
DR   PDBsum; 7KGJ; -.
DR   PDBsum; 7KGK; -.
DR   PDBsum; 7KJ2; -.
DR   PDBsum; 7KJ3; -.
DR   PDBsum; 7KJ4; -.
DR   PDBsum; 7KJ5; -.
DR   PDBsum; 7KKK; -.
DR   PDBsum; 7KKL; -.
DR   PDBsum; 7KL9; -.
DR   PDBsum; 7KLG; -.
DR   PDBsum; 7KLH; -.
DR   PDBsum; 7KLW; -.
DR   PDBsum; 7KMB; -.
DR   PDBsum; 7KMG; -.
DR   PDBsum; 7KMH; -.
DR   PDBsum; 7KMI; -.
DR   PDBsum; 7KMK; -.
DR   PDBsum; 7KML; -.
DR   PDBsum; 7KMS; -.
DR   PDBsum; 7KMZ; -.
DR   PDBsum; 7KN5; -.
DR   PDBsum; 7KN6; -.
DR   PDBsum; 7KN7; -.
DR   PDBsum; 7KNB; -.
DR   PDBsum; 7KNE; -.
DR   PDBsum; 7KNH; -.
DR   PDBsum; 7KNI; -.
DR   PDBsum; 7KQB; -.
DR   PDBsum; 7KQE; -.
DR   PDBsum; 7KRQ; -.
DR   PDBsum; 7KRR; -.
DR   PDBsum; 7KRS; -.
DR   PDBsum; 7KS9; -.
DR   PDBsum; 7KSG; -.
DR   PDBsum; 7KXJ; -.
DR   PDBsum; 7KXK; -.
DR   PDBsum; 7KZB; -.
DR   PDBsum; 7L02; -.
DR   PDBsum; 7L06; -.
DR   PDBsum; 7L09; -.
DR   PDBsum; 7L0N; -.
DR   PDBsum; 7L2C; -.
DR   PDBsum; 7L2D; -.
DR   PDBsum; 7L2E; -.
DR   PDBsum; 7L2F; -.
DR   PDBsum; 7L3N; -.
DR   PDBsum; 7L4Z; -.
DR   PDBsum; 7L56; -.
DR   PDBsum; 7L57; -.
DR   PDBsum; 7L58; -.
DR   PDBsum; 7L5B; -.
DR   PDBsum; 7L7F; -.
DR   PDBsum; 7L7K; -.
DR   PDBsum; 7LAA; -.
DR   PDBsum; 7LAB; -.
DR   PDBsum; 7LC8; -.
DR   PDBsum; 7LCN; -.
DR   PDBsum; 7LD1; -.
DR   PDBsum; 7LDJ; -.
DR   PDBsum; 7LJR; -.
DR   PDBsum; 7LM8; -.
DR   PDBsum; 7LO4; -.
DR   PDBsum; 7LOP; -.
DR   PDBsum; 7LQV; -.
DR   PDBsum; 7LQW; -.
DR   PDBsum; 7LS9; -.
DR   PDBsum; 7LSS; -.
DR   PDBsum; 7LWI; -.
DR   PDBsum; 7LWJ; -.
DR   PDBsum; 7LWK; -.
DR   PDBsum; 7LWL; -.
DR   PDBsum; 7LWM; -.
DR   PDBsum; 7LWN; -.
DR   PDBsum; 7LWO; -.
DR   PDBsum; 7LWP; -.
DR   PDBsum; 7LWQ; -.
DR   PDBsum; 7LWS; -.
DR   PDBsum; 7LWT; -.
DR   PDBsum; 7LWU; -.
DR   PDBsum; 7LWV; -.
DR   PDBsum; 7LWW; -.
DR   PDBsum; 7LX5; -.
DR   PDBsum; 7LXW; -.
DR   PDBsum; 7LXX; -.
DR   PDBsum; 7LXY; -.
DR   PDBsum; 7LXZ; -.
DR   PDBsum; 7LY0; -.
DR   PDBsum; 7LY2; -.
DR   PDBsum; 7LY3; -.
DR   PDBsum; 7LYK; -.
DR   PDBsum; 7LYL; -.
DR   PDBsum; 7LYM; -.
DR   PDBsum; 7LYN; -.
DR   PDBsum; 7LYO; -.
DR   PDBsum; 7LYP; -.
DR   PDBsum; 7LYQ; -.
DR   PDBsum; 7M0J; -.
DR   PDBsum; 7M3I; -.
DR   PDBsum; 7M53; -.
DR   PDBsum; 7M6D; -.
DR   PDBsum; 7M6E; -.
DR   PDBsum; 7M6F; -.
DR   PDBsum; 7M6G; -.
DR   PDBsum; 7M6H; -.
DR   PDBsum; 7M6I; -.
DR   PDBsum; 7M71; -.
DR   PDBsum; 7M7B; -.
DR   PDBsum; 7M7W; -.
DR   PDBsum; 7M8J; -.
DR   PDBsum; 7M8K; -.
DR   PDBsum; 7M8S; -.
DR   PDBsum; 7M8T; -.
DR   PDBsum; 7M8U; -.
DR   PDBsum; 7MF1; -.
DR   PDBsum; 7MFU; -.
DR   PDBsum; 7MJG; -.
DR   PDBsum; 7MJH; -.
DR   PDBsum; 7MJI; -.
DR   PDBsum; 7MJJ; -.
DR   PDBsum; 7MJK; -.
DR   PDBsum; 7MJL; -.
DR   PDBsum; 7MJM; -.
DR   PDBsum; 7MJN; -.
DR   PDBsum; 7MKB; -.
DR   PDBsum; 7MKL; -.
DR   PDBsum; 7MKM; -.
DR   PDBsum; 7MMO; -.
DR   PDBsum; 7MY2; -.
DR   PDBsum; 7MY3; -.
DR   PDBsum; 7N0G; -.
DR   PDBsum; 7N0H; -.
DR   PDBsum; 7ND3; -.
DR   PDBsum; 7ND4; -.
DR   PDBsum; 7ND5; -.
DR   PDBsum; 7ND6; -.
DR   PDBsum; 7ND7; -.
DR   PDBsum; 7ND8; -.
DR   PDBsum; 7ND9; -.
DR   PDBsum; 7NDA; -.
DR   PDBsum; 7NDB; -.
DR   PDBsum; 7NDC; -.
DR   PDBsum; 7NDD; -.
DR   PDBsum; 7NEG; -.
DR   PDBsum; 7NEH; -.
DR   PDBsum; 7NKT; -.
DR   PDBsum; 7NT9; -.
DR   PDBsum; 7NTA; -.
DR   PDBsum; 7NTC; -.
DR   PDBsum; 7NX6; -.
DR   PDBsum; 7NX7; -.
DR   PDBsum; 7NX8; -.
DR   PDBsum; 7NX9; -.
DR   PDBsum; 7NXA; -.
DR   PDBsum; 7NXB; -.
DR   PDBsum; 7NXC; -.
DR   SASBDB; P0DTC2; -.
DR   SMR; P0DTC2; -.
DR   BioGRID; 4383848; 638.
DR   ComplexPortal; CPX-5682; SARS-CoV-2 Spike protein complex.
DR   IntAct; P0DTC2; 49.
DR   DrugBank; DB15691; Anti-SARS-CoV-2 REGN-COV2.
DR   DrugBank; DB15718; Bamlanivimab.
DR   DrugBank; DB15941; Casirivimab.
DR   DrugBank; DB15897; Etesevimab.
DR   DrugBank; DB15940; Imdevimab.
DR   GlyConnect; 2838; 126 N-Linked glycans (16 sites), 4 O-Linked glycans (2 sites).
DR   GlyConnect; 2839; 81 N-Linked glycans (21 sites).
DR   GlyConnect; 2840; 109 N-Linked glycans (22 sites).
DR   GlyConnect; 2951; 2 O-Linked glycans (6 sites).
DR   GlyConnect; 2952; 2 O-Linked glycans (18 sites).
DR   GlyConnect; 2953; 2 O-Linked glycans (13 sites).
DR   GlyConnect; 2956; 34 N-Linked glycans (2 sites), 20 O-Linked glycans (1 site).
DR   GlyConnect; 2957; 19 N-Linked glycans (2 sites), 17 O-Linked glycans (1 site).
DR   GlyGen; P0DTC2; 25 sites, 386 N-linked glycans (23 sites), 6 O-linked glycans (2 sites).
DR   ABCD; P0DTC2; 887 sequenced antibodies.
DR   DNASU; 43740568; -.
DR   GeneID; 43740568; -.
DR   KEGG; vg:43740568; -.
DR   Reactome; R-HSA-9694322; Virion Assembly and Release.
DR   Reactome; R-HSA-9694548; Maturation of spike protein.
DR   Reactome; R-HSA-9694614; Attachment and Entry.
DR   Reactome; R-HSA-9694635; Translation of structural proteins.
DR   SABIO-RK; P0DTC2; -.
DR   SIGNOR; P0DTC2; -.
DR   PRO; PR:P0DTC2; -.
DR   Proteomes; UP000464024; Genome.
DR   GO; GO:0030666; C:endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; TAS:Reactome.
DR   GO; GO:0005793; C:endoplasmic reticulum-Golgi intermediate compartment; TAS:Reactome.
DR   GO; GO:0044173; C:host cell endoplasmic reticulum-Golgi intermediate compartment membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0020002; C:host cell plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-UniRule.
DR   GO; GO:0019031; C:viral envelope; IEA:UniProtKB-UniRule.
DR   GO; GO:0055036; C:virion membrane; TAS:Reactome.
DR   GO; GO:0046789; F:host cell surface receptor binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0075509; P:endocytosis involved in viral entry into host cell; IEA:UniProtKB-UniRule.
DR   GO; GO:0039654; P:fusion of virus membrane with host endosome membrane; IEA:UniProtKB-UniRule.
DR   GO; GO:0019064; P:fusion of virus membrane with host plasma membrane; IEA:UniProtKB-UniRule.
DR   GO; GO:0046813; P:receptor-mediated virion attachment to host cell; IEA:UniProtKB-UniRule.
DR   GO; GO:0039587; P:suppression by virus of host tetherin activity; IEA:UniProtKB-KW.
DR   GO; GO:0039502; P:suppression by virus of host type I interferon-mediated signaling pathway; IEA:UniProtKB-KW.
DR   GO; GO:0046718; P:viral entry into host cell; IDA:UniProtKB.
DR   CDD; cd21480; SARS-CoV-2_Spike_S1_RBD; 1.
DR   CDD; cd21624; SARS-CoV-like_Spike_S1_NTD; 1.
DR   DisProt; DP02772; -.
DR   Gene3D; 2.60.120.960; -; 1.
DR   HAMAP; MF_04099; BETA_CORONA_SPIKE; 1.
DR   InterPro; IPR032500; bCoV_S1_N.
DR   InterPro; IPR042578; BETA_CORONA_SPIKE.
DR   InterPro; IPR043607; CoV_S1_C.
DR   InterPro; IPR043473; S2_sf_CoV.
DR   InterPro; IPR043002; Spike_N_sf.
DR   InterPro; IPR036326; Spike_rcpt-bd_sf_CoV.
DR   InterPro; IPR044341; Spike_S1_N_SARS-CoV-like.
DR   InterPro; IPR018548; Spike_S1_RBD_bCoV.
DR   InterPro; IPR044366; Spike_S1_RBD_SARS-CoV-2.
DR   InterPro; IPR002552; Spike_S2_CoV.
DR   InterPro; IPR044873; Spike_S2_CoV_HR1.
DR   InterPro; IPR044874; Spike_S2_CoV_HR2.
DR   Pfam; PF16451; bCoV_S1_N; 1.
DR   Pfam; PF09408; bCoV_S1_RBD; 1.
DR   Pfam; PF19209; CoV_S1_C; 1.
DR   Pfam; PF01601; CoV_S2; 1.
DR   SUPFAM; SSF111474; SSF111474; 2.
DR   SUPFAM; SSF143587; SSF143587; 1.
DR   PROSITE; PS51921; BCOV_S1_CTD; 1.
DR   PROSITE; PS51922; BCOV_S1_NTD; 1.
DR   PROSITE; PS51923; COV_S2_HR1; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Coiled coil; Disulfide bond;
KW   Fusion of virus membrane with host endosomal membrane;
KW   Fusion of virus membrane with host membrane; Glycoprotein;
KW   Host cell membrane; Host membrane; Host-virus interaction;
KW   Inhibition of host innate immune response by virus;
KW   Inhibition of host interferon signaling pathway by virus;
KW   Inhibition of host tetherin by virus; Lipoprotein; Membrane; Palmitate;
KW   Reference proteome; Signal; Transmembrane; Transmembrane helix;
KW   Viral attachment to host cell; Viral envelope protein; Viral immunoevasion;
KW   Viral penetration into host cytoplasm; Virion; Virulence;
KW   Virus entry into host cell.
FT   SIGNAL          1..12
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099"
FT   CHAIN           13..1273
FT                   /note="Spike glycoprotein"
FT                   /id="PRO_0000449646"
FT   CHAIN           13..685
FT                   /note="Spike protein S1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099"
FT                   /id="PRO_0000449647"
FT   CHAIN           686..1273
FT                   /note="Spike protein S2"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099"
FT                   /id="PRO_0000449648"
FT   CHAIN           816..1273
FT                   /note="Spike protein S2'"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099"
FT                   /id="PRO_0000449649"
FT   TOPO_DOM        13..1213
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099"
FT   TRANSMEM        1214..1234
FT                   /note="Helical"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099"
FT   TOPO_DOM        1235..1273
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099"
FT   DOMAIN          13..303
FT                   /note="BetaCoV S1-NTD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01270"
FT   DOMAIN          334..527
FT                   /note="BetaCoV S1-CTD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01269,
FT                   ECO:0000269|PubMed:32132184"
FT   REGION          319..541
FT                   /note="Receptor-binding domain (RBD)"
FT                   /evidence="ECO:0000269|PubMed:32132184"
FT   REGION          403..405
FT                   /note="Integrin-binding motif;"
FT                   /evidence="ECO:0000269|PubMed:33102950"
FT   REGION          437..508
FT                   /note="Receptor-binding motif; binding to human ACE2"
FT                   /evidence="ECO:0000250|UniProtKB:P59594"
FT   REGION          448..456
FT                   /note="Immunodominant HLA epitope recognized by the CD8+;
FT                   called NF9 peptide"
FT                   /evidence="ECO:0000269|PubMed:34171266"
FT   REGION          816..837
FT                   /note="Fusion peptide 1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099"
FT   REGION          835..855
FT                   /note="Fusion peptide 2"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099"
FT   REGION          920..970
FT                   /note="Heptad repeat 1"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099"
FT   REGION          1163..1202
FT                   /note="Heptad repeat 2"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099"
FT   COILED          949..993
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099"
FT   COILED          1176..1203
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099"
FT   MOTIF           1269..1273
FT                   /note="KxHxx"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099"
FT   SITE            685..686
FT                   /note="Cleavage; by TMPRSS2 or furin"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32142651, ECO:0000269|PubMed:32362314"
FT   SITE            815..816
FT                   /note="Cleavage; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099"
FT   CARBOHYD        17
FT                   /note="N-linked (GlcNAc...) (complex) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        61
FT                   /note="N-linked (GlcNAc...) (hybrid) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32363391,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        74
FT                   /note="N-linked (GlcNAc...) (complex) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32363391, ECO:0000269|PubMed:32366695,
FT                   ECO:0000269|PubMed:32979942"
FT   CARBOHYD        122
FT                   /note="N-linked (GlcNAc...) (hybrid) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32363391,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        149
FT                   /note="N-linked (GlcNAc...) (complex) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32363391, ECO:0000269|PubMed:32366695,
FT                   ECO:0000269|PubMed:32979942"
FT   CARBOHYD        165
FT                   /note="N-linked (GlcNAc...) (complex) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32363391,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        234
FT                   /note="N-linked (GlcNAc...) (high mannose) asparagine; by
FT                   host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32363391,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        282
FT                   /note="N-linked (GlcNAc...) (complex) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32363391,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        323
FT                   /note="O-linked (GalNAc) threonine; by host"
FT                   /evidence="ECO:0000269|PubMed:32363391"
FT   CARBOHYD        325
FT                   /note="O-linked (HexNAc...) serine; by host"
FT                   /evidence="ECO:0000269|PubMed:32363391"
FT   CARBOHYD        331
FT                   /note="N-linked (GlcNAc...) (complex) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32363391,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        343
FT                   /note="N-linked (GlcNAc...) (complex) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32363391,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        603
FT                   /note="N-linked (GlcNAc...) (hybrid) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32366695,
FT                   ECO:0000269|PubMed:32979942"
FT   CARBOHYD        616
FT                   /note="N-linked (GlcNAc...) (complex) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32363391,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        657
FT                   /note="N-linked (GlcNAc...) (complex) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32363391,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        709
FT                   /note="N-linked (GlcNAc...) (high mannose) asparagine; by
FT                   host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32363391,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        717
FT                   /note="N-linked (GlcNAc...) (hybrid) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32363391,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        801
FT                   /note="N-linked (GlcNAc...) (hybrid) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32363391,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        1074
FT                   /note="N-linked (GlcNAc...) (hybrid) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32363391,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        1098
FT                   /note="N-linked (GlcNAc...) (complex) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32363391,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        1134
FT                   /note="N-linked (GlcNAc...) (complex) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32366695,
FT                   ECO:0000269|PubMed:32979942"
FT   CARBOHYD        1158
FT                   /note="N-linked (GlcNAc...) (complex) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        1173
FT                   /note="N-linked (GlcNAc...) (complex) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32366695, ECO:0000269|PubMed:32979942"
FT   CARBOHYD        1194
FT                   /note="N-linked (GlcNAc...) (complex) asparagine; by host"
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099,
FT                   ECO:0000269|PubMed:32363391, ECO:0000269|PubMed:32366695,
FT                   ECO:0000269|PubMed:32979942"
FT   DISULFID        15..136
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01270"
FT   DISULFID        131..166
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01270,
FT                   ECO:0000269|PubMed:32155444, ECO:0007744|PDB:6VXX"
FT   DISULFID        291..301
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01270,
FT                   ECO:0000269|PubMed:32155444, ECO:0007744|PDB:6VXX"
FT   DISULFID        336..361
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01269,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32245784"
FT   DISULFID        379..432
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01269,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32245784"
FT   DISULFID        391..525
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01269,
FT                   ECO:0000269|PubMed:32155444, ECO:0000269|PubMed:32225175,
FT                   ECO:0000269|PubMed:32225176, ECO:0000269|PubMed:32245784,
FT                   ECO:0007744|PDB:6VXX"
FT   DISULFID        480..488
FT                   /evidence="ECO:0000269|PubMed:32245784"
FT   DISULFID        538..590
FT                   /evidence="ECO:0000269|PubMed:32155444,
FT                   ECO:0007744|PDB:6VXX"
FT   DISULFID        617..649
FT                   /evidence="ECO:0000269|PubMed:32155444,
FT                   ECO:0007744|PDB:6VXX"
FT   DISULFID        662..671
FT                   /evidence="ECO:0000269|PubMed:32155444,
FT                   ECO:0007744|PDB:6VXX"
FT   DISULFID        738..760
FT                   /evidence="ECO:0000269|PubMed:32155444,
FT                   ECO:0007744|PDB:6VXX"
FT   DISULFID        743..749
FT                   /evidence="ECO:0000269|PubMed:32155444,
FT                   ECO:0007744|PDB:6VXX"
FT   DISULFID        840..851
FT                   /evidence="ECO:0000255|HAMAP-Rule:MF_04099"
FT   DISULFID        1032..1043
FT                   /evidence="ECO:0000269|PubMed:32155444,
FT                   ECO:0007744|PDB:6VXX"
FT   DISULFID        1082..1126
FT                   /evidence="ECO:0000269|PubMed:32155444,
FT                   ECO:0007744|PDB:6VXX"
FT   VARIANT         5
FT                   /note="L -> F (in strain: Iota/B.1.526)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         13
FT                   /note="S -> I (in strain: Epsilon/B.1.429)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         18
FT                   /note="L -> F (in strain: Beta/B.1.351, Gamma/P.1,
FT                   19B/501Y)"
FT                   /evidence="ECO:0000305, ECO:0000305|PubMed:33690265"
FT   VARIANT         19
FT                   /note="T -> R (in strain: Delta/B.1.617.2)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         20
FT                   /note="T -> N (in strain: Gamma/P.1)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         26
FT                   /note="P -> S (in strain: Gamma/P.1)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         67
FT                   /note="A -> V (in strain: Eta/B.1.525)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         69..70
FT                   /note="Missing (in strain: Alpha/B.1.1.7, Eta/B.1.525,
FT                   19B/501T; May compensate for reduced infectivity of RBD
FT                   escape mutants)"
FT                   /evidence="ECO:0000269|PubMed:34166617,
FT                   ECO:0000305|PubMed:33413740"
FT   VARIANT         75
FT                   /note="G -> V (in strain: Lambda/C.37)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         76
FT                   /note="T -> I (in strain: Lambda/C.37)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         80
FT                   /note="D -> A (in strain: Beta/B.1.351)"
FT                   /evidence="ECO:0000305|PubMed:33690265"
FT   VARIANT         95
FT                   /note="T -> I (in strain: Iota/B.1.526, B.1.1.318)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         102
FT                   /note="R -> I (in strain: A23.1)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         138
FT                   /note="D -> Y (in strain: Gamma/P.1)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         142
FT                   /note="G -> D (in strain: Kappa/B.1.617.1)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         144
FT                   /note="Missing (in strain: Alpha/B.1.1.7, Eta/B.1.525,
FT                   B.1.1.318)"
FT                   /evidence="ECO:0000305, ECO:0000305|PubMed:33413740"
FT   VARIANT         152
FT                   /note="W -> C (frequently in strain Epsilon/B.1.429)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         154
FT                   /note="E -> K (in strain: Kappa/B.1.617.1)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         156..158
FT                   /note="EFR -> G (in strain: Delta/B.1.617.2)"
FT   VARIANT         157
FT                   /note="F -> L (in strain: A23.1)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         190
FT                   /note="R -> S (in strain: Gamma/P.1)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         215
FT                   /note="D -> G (in strain: Beta/B.1.351)"
FT                   /evidence="ECO:0000305|PubMed:33690265"
FT   VARIANT         222
FT                   /note="A -> V (in strain: 20A.EU1)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         246..252
FT                   /note="Missing (in strain: Lambda/C.37)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         253
FT                   /note="D -> G (in strain: Iota/B.1.526)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         417
FT                   /note="K -> N (in strain: Beta/B.1.351, Gamma/P.1; May
FT                   enhance affinity to human ACE2 receptor)"
FT                   /evidence="ECO:0000305|PubMed:33690265"
FT   VARIANT         417
FT                   /note="K -> T (in strain: Gamma/P.1)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         452
FT                   /note="L -> R (in strain: Delta/B.1.617.2, Epsilon/B.1.429,
FT                   Kappa/B.1.617.1, Lambda/C.37, 19B/501Y; Contributes to
FT                   cellular immunity evasion and increases infectivity)"
FT                   /evidence="ECO:0000269|PubMed:34171266, ECO:0000305"
FT   VARIANT         453
FT                   /note="Y -> F (in strain: B.1.1.298)"
FT                   /evidence="ECO:0000269|PubMed:34171266"
FT   VARIANT         477
FT                   /note="S -> N (in strain: 20A.EU2, Iota/B.1.526)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         478
FT                   /note="T -> K (in strain: Delta/B.1.617.2)"
FT   VARIANT         484
FT                   /note="E -> K (in strain: Beta/B.1.351, Eta/B.1.525,
FT                   Theta/P.3, Iota/B.1.526, B.1.1.318, Gamma/P.1, Zeta/P.2;
FT                   May enhance affinity to human ACE2 receptor)"
FT                   /evidence="ECO:0000305, ECO:0000305|PubMed:33690265"
FT   VARIANT         484
FT                   /note="E -> Q (in strain: Kappa/B.1.617.1)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         490
FT                   /note="F -> S (in strain: Lambda/C.37)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         501
FT                   /note="N -> T (in strain: 19B/501T)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         501
FT                   /note="N -> Y (in strain: Alpha/B.1.1.7, Beta/B.1.351,
FT                   Gamma/P.1, Theta/P.3, 19B/501Y; May enhance affinity to
FT                   human ACE2 receptor)"
FT                   /evidence="ECO:0000269|PubMed:32732280, ECO:0000305,
FT                   ECO:0000305|PubMed:33413740, ECO:0000305|PubMed:33690265"
FT   VARIANT         570
FT                   /note="A -> D (in strain: Alpha/B.1.1.7)"
FT                   /evidence="ECO:0000305|PubMed:33413740"
FT   VARIANT         613
FT                   /note="Q -> H (in strain: A23.1)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         614
FT                   /note="D -> G (in strain Alpha/B.1.1.7, Beta/B.1.351,
FT                   Gamma/P.1, Delta/B.1.617.2, Epsilon/B.1.429, Eta/B.1.525,
FT                   Theta/P.3, Iota/B.1.526, Kappa/B.1.617.1, Lambda/C.37,
FT                   B.1.1.318, Zeta/P.2, 20A.EU1, 20A.EU2; common variant;
FT                   binds to hACE2 more efficiently; produces more infectious
FT                   particles when cultured in primary human epithelial cells;
FT                   does not significantly shift SARS-CoV-2 neutralization
FT                   properties)"
FT                   /evidence="ECO:0000305, ECO:0000305|PubMed:32132184,
FT                   ECO:0000305|PubMed:32697968, ECO:0000305|PubMed:32820179,
FT                   ECO:0000305|PubMed:33106671, ECO:0000305|PubMed:33184236,
FT                   ECO:0000305|PubMed:33413740, ECO:0000305|PubMed:33636719"
FT   VARIANT         653
FT                   /note="A -> V (in strain: 19B/501Y)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         655
FT                   /note="H -> Y (in strain: Gamma/P.1, 19B/501T, 19B/501Y)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         677
FT                   /note="Q -> H (in strain: Eta/B.1.525)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         681
FT                   /note="P -> H (in strain: Alpha/B.1.1.7, Theta/P.3,
FT                   B.1.1.318, A23.1)"
FT                   /evidence="ECO:0000305|PubMed:33413740"
FT   VARIANT         681
FT                   /note="P -> R (in strain: Delta/B.1.617.2,
FT                   Kappa/B.1.617.1)"
FT   VARIANT         701
FT                   /note="A -> V (in strain: Beta/B1.351, Iota/B.1.526)"
FT                   /evidence="ECO:0000305, ECO:0000305|PubMed:33690265"
FT   VARIANT         716
FT                   /note="T -> I (in strain: Alpha/B.1.1.7)"
FT                   /evidence="ECO:0000305|PubMed:33413740"
FT   VARIANT         796
FT                   /note="D -> H (in strain: B.1.1.318)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         796
FT                   /note="D -> Y (in strain: 19B/501Y)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         859
FT                   /note="T -> N (in strain: Lambda/C.37)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         888
FT                   /note="F -> L (in strain: Eta/B.1.525)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         950
FT                   /note="D -> N (in strain: Delta/B.1.617.2)"
FT   VARIANT         982
FT                   /note="S -> A (in strain: Alpha/B.1.1.7)"
FT                   /evidence="ECO:0000305|PubMed:33413740"
FT   VARIANT         1027
FT                   /note="T -> I (in strain: Gamma/P.1)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         1071
FT                   /note="Q -> H (in strain: Kappa/B.1.617.1)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         1092
FT                   /note="E -> K (in strain: Theta/P.3)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         1101
FT                   /note="H -> Y (in strain: Theta/P.3)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         1118
FT                   /note="D -> H (in strain: Alpha/B.1.1.7)"
FT                   /evidence="ECO:0000305|PubMed:33413740"
FT   VARIANT         1176
FT                   /note="V -> F (in strain: Gamma/P.1, Theta/P.3, Zeta/P.2)"
FT                   /evidence="ECO:0000305"
FT   VARIANT         1219
FT                   /note="G -> V (in strain: 19B/501Y)"
FT                   /evidence="ECO:0000305"
FT   MUTAGEN         69..70
FT                   /note="Missing: Increased incorporation of cleaved spike
FT                   into virions."
FT                   /evidence="ECO:0000269|PubMed:34166617"
FT   MUTAGEN         234
FT                   /note="N->Q: Increased resistance to neutralizing
FT                   antibodies."
FT                   /evidence="ECO:0000269|PubMed:32730807"
FT   MUTAGEN         331
FT                   /note="N->Q: Reduced viral infectivity."
FT                   /evidence="ECO:0000269|PubMed:32730807"
FT   MUTAGEN         343
FT                   /note="N->Q: Reduced viral infectivity."
FT                   /evidence="ECO:0000269|PubMed:32730807"
FT   MUTAGEN         452
FT                   /note="L->R: Increased resistance to neutralizing
FT                   antibodies. Decreases HLA binding to NF9 epitope. Increased
FT                   binding affinity to human ACE2."
FT                   /evidence="ECO:0000269|PubMed:32730807,
FT                   ECO:0000269|PubMed:34171266"
FT   MUTAGEN         453
FT                   /note="Y->F: Decreased HLA binding to NF9 epitope.
FT                   Increased binding affinity to human ACE2."
FT                   /evidence="ECO:0000269|PubMed:34171266"
FT   MUTAGEN         475
FT                   /note="A->V: Increased resistance to neutralizing
FT                   antibodies."
FT                   /evidence="ECO:0000269|PubMed:32730807"
FT   MUTAGEN         483
FT                   /note="V->A: Increased resistance to neutralizing
FT                   antibodies."
FT                   /evidence="ECO:0000269|PubMed:32730807"
FT   MUTAGEN         490
FT                   /note="F->L: Increased resistance to neutralizing
FT                   antibodies and human covalescent sera neutralization."
FT                   /evidence="ECO:0000269|PubMed:32730807"
FT   MUTAGEN         493
FT                   /note="Q->N: Reduced host ACE2-binding affinity in vitro."
FT                   /evidence="ECO:0000269|PubMed:32225175"
FT   MUTAGEN         493
FT                   /note="Q->Y: Reduced host ACE2-binding affinity in vitro."
FT                   /evidence="ECO:0000269|PubMed:32225175"
FT   MUTAGEN         501
FT                   /note="N->T: Reduced host ACE2-binding affinity in vitro."
FT                   /evidence="ECO:0000269|PubMed:32225175"
FT   MUTAGEN         501
FT                   /note="N->Y: Increased binding affinity to human ACE2."
FT                   /evidence="ECO:0000269|PubMed:34171266"
FT   MUTAGEN         519
FT                   /note="H->P: Increased resistance to human covalescent sera
FT                   neutralization."
FT                   /evidence="ECO:0000269|PubMed:32730807"
FT   MUTAGEN         614
FT                   /note="D->G: Increase of pseudotyped VSV particle
FT                   production ex vivo. Increase of viral load in hamster upper
FT                   respiratory tract. Produces more infectious particles when
FT                   cultured in primary human epithelial cells; increases
FT                   replication and transmissibility in hamsters and ferrets."
FT                   /evidence="ECO:0000269|PubMed:32697968,
FT                   ECO:0000269|PubMed:33106671, ECO:0000269|PubMed:33636719"
FT   MUTAGEN         679..684
FT                   /note="NSPRRA->IL: About 50% stronger entry efficiency in
FT                   Vero E6 cells while 30% weaker entry efficiency in
FT                   hACE2-expressing BHK cells."
FT                   /evidence="ECO:0000269|PubMed:32155444"
FT   MUTAGEN         681..684
FT                   /note="PRRA->RRRK: Optimized cleavage by host furin."
FT                   /evidence="ECO:0000269|PubMed:32362314"
FT   MUTAGEN         682..684
FT                   /note="Missing: Complete loss of cleavage by host furin."
FT                   /evidence="ECO:0000269|PubMed:32362314"
FT   STRAND          28..30
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   TURN            32..35
FT                   /evidence="ECO:0007829|PDB:7KEA"
FT   STRAND          40..43
FT                   /evidence="ECO:0007829|PDB:7K43"
FT   STRAND          48..55
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          61..65
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          72..74
FT                   /evidence="ECO:0007829|PDB:7CWN"
FT   STRAND          77..79
FT                   /evidence="ECO:0007829|PDB:7CWN"
FT   STRAND          83..85
FT                   /evidence="ECO:0007829|PDB:6ZGE"
FT   STRAND          90..94
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          97..99
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          104..108
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          111..114
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          117..121
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          122..125
FT                   /evidence="ECO:0007829|PDB:7KEA"
FT   STRAND          126..129
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          132..142
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   TURN            147..150
FT                   /evidence="ECO:0007829|PDB:6ZGE"
FT   STRAND          152..155
FT                   /evidence="ECO:0007829|PDB:7CWN"
FT   STRAND          157..164
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          169..172
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          184..186
FT                   /evidence="ECO:0007829|PDB:7DF3"
FT   STRAND          189..195
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          201..208
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          212..215
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          222..229
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          237..240
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          243..246
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   TURN            254..256
FT                   /evidence="ECO:0007829|PDB:6ZGE"
FT   STRAND          265..269
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          271..279
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          281..283
FT                   /evidence="ECO:0007829|PDB:7DF3"
FT   STRAND          285..290
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   TURN            291..293
FT                   /evidence="ECO:0007829|PDB:6XEY"
FT   HELIX           295..303
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          305..307
FT                   /evidence="ECO:0007829|PDB:7DDD"
FT   STRAND          310..319
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          324..328
FT                   /evidence="ECO:0007829|PDB:6ZGE"
FT   HELIX           332..334
FT                   /evidence="ECO:0007829|PDB:7D2Z"
FT   HELIX           339..342
FT                   /evidence="ECO:0007829|PDB:7JMP"
FT   STRAND          343..345
FT                   /evidence="ECO:0007829|PDB:7BEP"
FT   HELIX           350..352
FT                   /evidence="ECO:0007829|PDB:7JMP"
FT   STRAND          354..358
FT                   /evidence="ECO:0007829|PDB:7JMP"
FT   STRAND          360..362
FT                   /evidence="ECO:0007829|PDB:7KMH"
FT   HELIX           366..369
FT                   /evidence="ECO:0007829|PDB:7KMH"
FT   STRAND          370..372
FT                   /evidence="ECO:0007829|PDB:7KN5"
FT   STRAND          375..382
FT                   /evidence="ECO:0007829|PDB:7JMP"
FT   HELIX           384..389
FT                   /evidence="ECO:0007829|PDB:7KMH"
FT   STRAND          391..393
FT                   /evidence="ECO:0007829|PDB:7KN5"
FT   STRAND          395..403
FT                   /evidence="ECO:0007829|PDB:7JMP"
FT   HELIX           404..409
FT                   /evidence="ECO:0007829|PDB:7JMP"
FT   STRAND          410..413
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   HELIX           417..421
FT                   /evidence="ECO:0007829|PDB:7JMP"
FT   HELIX           427..429
FT                   /evidence="ECO:0007829|PDB:7LD1"
FT   STRAND          431..437
FT                   /evidence="ECO:0007829|PDB:7JMP"
FT   HELIX           439..442
FT                   /evidence="ECO:0007829|PDB:7JMP"
FT   TURN            444..447
FT                   /evidence="ECO:0007829|PDB:7K90"
FT   HELIX           448..450
FT                   /evidence="ECO:0007829|PDB:7LD1"
FT   STRAND          452..454
FT                   /evidence="ECO:0007829|PDB:7JMP"
FT   STRAND          457..459
FT                   /evidence="ECO:0007829|PDB:7C2L"
FT   TURN            463..466
FT                   /evidence="ECO:0007829|PDB:7LD1"
FT   STRAND          470..472
FT                   /evidence="ECO:0007829|PDB:7LD1"
FT   STRAND          476..478
FT                   /evidence="ECO:0007829|PDB:7JMP"
FT   STRAND          481..483
FT                   /evidence="ECO:0007829|PDB:7C8W"
FT   STRAND          485..489
FT                   /evidence="ECO:0007829|PDB:6ZB5"
FT   STRAND          491..494
FT                   /evidence="ECO:0007829|PDB:7JMP"
FT   STRAND          499..501
FT                   /evidence="ECO:0007829|PDB:6ZGE"
FT   HELIX           503..505
FT                   /evidence="ECO:0007829|PDB:7JMP"
FT   STRAND          506..515
FT                   /evidence="ECO:0007829|PDB:7JMP"
FT   STRAND          518..520
FT                   /evidence="ECO:0007829|PDB:6ZGE"
FT   STRAND          524..526
FT                   /evidence="ECO:0007829|PDB:7NEH"
FT   TURN            528..530
FT                   /evidence="ECO:0007829|PDB:7L0N"
FT   STRAND          536..543
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          546..554
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          565..567
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   TURN            569..571
FT                   /evidence="ECO:0007829|PDB:6ZXN"
FT   STRAND          573..577
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          579..581
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          584..588
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          592..599
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   TURN            602..604
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          609..613
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   HELIX           617..619
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   HELIX           620..623
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   TURN            624..628
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   HELIX           631..634
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          637..640
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          642..645
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          648..652
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          654..660
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          663..667
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          670..675
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          691..697
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          701..703
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          709..716
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          718..728
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          733..736
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   HELIX           738..743
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   HELIX           747..753
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   HELIX           754..756
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   HELIX           759..782
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          787..789
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   HELIX           797..799
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   TURN            803..805
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          806..808
FT                   /evidence="ECO:0007829|PDB:7DF3"
FT   STRAND          809..813
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   HELIX           817..823
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          829..833
FT                   /evidence="ECO:0007829|PDB:7DF3"
FT   HELIX           835..838
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          842..845
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   HELIX           849..854
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   TURN            855..857
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          858..861
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   HELIX           867..884
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          885..887
FT                   /evidence="ECO:0007829|PDB:6ZB5"
FT   TURN            888..890
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   HELIX           898..908
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   HELIX           913..918
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   HELIX           919..966
FT                   /evidence="ECO:0007829|PDB:6M1V"
FT   STRAND          970..973
FT                   /evidence="ECO:0007829|PDB:6ZB5"
FT   HELIX           977..983
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   TURN            986..989
FT                   /evidence="ECO:0007829|PDB:6ZB4"
FT   HELIX           1009..1021
FT                   /evidence="ECO:0007829|PDB:6M1V"
FT   HELIX           1022..1025
FT                   /evidence="ECO:0007829|PDB:6M1V"
FT   HELIX           1029..1031
FT                   /evidence="ECO:0007829|PDB:6M1V"
FT   TURN            1032..1034
FT                   /evidence="ECO:0007829|PDB:7A29"
FT   TURN            1040..1043
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          1044..1056
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          1059..1069
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          1072..1079
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          1081..1085
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          1087..1100
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          1102..1105
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          1107..1109
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          1112..1114
FT                   /evidence="ECO:0007829|PDB:6X6P"
FT   STRAND          1116..1122
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   STRAND          1126..1128
FT                   /evidence="ECO:0007829|PDB:6ZGE"
FT   STRAND          1129..1131
FT                   /evidence="ECO:0007829|PDB:7ND9"
FT   STRAND          1132..1134
FT                   /evidence="ECO:0007829|PDB:6X2C"
FT   STRAND          1140..1142
FT                   /evidence="ECO:0007829|PDB:6XLU"
FT   HELIX           1143..1145
FT                   /evidence="ECO:0007829|PDB:6XEY"
FT   TURN            1146..1149
FT                   /evidence="ECO:0007829|PDB:7JZL"
FT   HELIX           1170..1201
FT                   /evidence="ECO:0007829|PDB:6LVN"
SQ   SEQUENCE   1273 AA;  141178 MW;  B17BE6D9F1C4EA34 CRC64;
     MFVFLVLLPL VSSQCVNLTT RTQLPPAYTN SFTRGVYYPD KVFRSSVLHS TQDLFLPFFS
     NVTWFHAIHV SGTNGTKRFD NPVLPFNDGV YFASTEKSNI IRGWIFGTTL DSKTQSLLIV
     NNATNVVIKV CEFQFCNDPF LGVYYHKNNK SWMESEFRVY SSANNCTFEY VSQPFLMDLE
     GKQGNFKNLR EFVFKNIDGY FKIYSKHTPI NLVRDLPQGF SALEPLVDLP IGINITRFQT
     LLALHRSYLT PGDSSSGWTA GAAAYYVGYL QPRTFLLKYN ENGTITDAVD CALDPLSETK
     CTLKSFTVEK GIYQTSNFRV QPTESIVRFP NITNLCPFGE VFNATRFASV YAWNRKRISN
     CVADYSVLYN SASFSTFKCY GVSPTKLNDL CFTNVYADSF VIRGDEVRQI APGQTGKIAD
     YNYKLPDDFT GCVIAWNSNN LDSKVGGNYN YLYRLFRKSN LKPFERDIST EIYQAGSTPC
     NGVEGFNCYF PLQSYGFQPT NGVGYQPYRV VVLSFELLHA PATVCGPKKS TNLVKNKCVN
     FNFNGLTGTG VLTESNKKFL PFQQFGRDIA DTTDAVRDPQ TLEILDITPC SFGGVSVITP
     GTNTSNQVAV LYQDVNCTEV PVAIHADQLT PTWRVYSTGS NVFQTRAGCL IGAEHVNNSY
     ECDIPIGAGI CASYQTQTNS PRRARSVASQ SIIAYTMSLG AENSVAYSNN SIAIPTNFTI
     SVTTEILPVS MTKTSVDCTM YICGDSTECS NLLLQYGSFC TQLNRALTGI AVEQDKNTQE
     VFAQVKQIYK TPPIKDFGGF NFSQILPDPS KPSKRSFIED LLFNKVTLAD AGFIKQYGDC
     LGDIAARDLI CAQKFNGLTV LPPLLTDEMI AQYTSALLAG TITSGWTFGA GAALQIPFAM
     QMAYRFNGIG VTQNVLYENQ KLIANQFNSA IGKIQDSLSS TASALGKLQD VVNQNAQALN
     TLVKQLSSNF GAISSVLNDI LSRLDKVEAE VQIDRLITGR LQSLQTYVTQ QLIRAAEIRA
     SANLAATKMS ECVLGQSKRV DFCGKGYHLM SFPQSAPHGV VFLHVTYVPA QEKNFTTAPA
     ICHDGKAHFP REGVFVSNGT HWFVTQRNFY EPQIITTDNT FVSGNCDVVI GIVNNTVYDP
     LQPELDSFKE ELDKYFKNHT SPDVDLGDIS GINASVVNIQ KEIDRLNEVA KNLNESLIDL
     QELGKYEQYI KWPWYIWLGF IAGLIAIVMV TIMLCCMTSC CSCLKGCCSC GSCCKFDEDD
     SEPVLKGVKL HYT
//
